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ABSTRACT 
Generalized Anxiety Disorder (GAD) is one of the most common and impairing 
childhood anxiety disorders, impacting over 10% of children with an average age of onset 
at 8.5 years. GAD in childhood increases the risk for developing additional anxiety and 
depressive disorders, academic and social difficulties, and, if left untreated, continuity 
into adulthood. While treatments incorporating mindfulness techniques have been shown 
to be efficacious among adults, relatively few studies have examined the efficacy of these 
techniques in the treatment of children. Mindfulness skills may be able to target 
maladaptive cognitive patterns by teaching children more flexible ways of thinking and 
viewing the world and providing children additional coping skills that may positively 
impact their overall functioning long-term. The aim of the present study was to develop 
and provide preliminary evaluation of a mindfulness-based intervention for GAD in 
school-aged children.  
Four children aged 9 to 12 with a principal diagnosis of GAD completed an open 
trial pilot phase of a 6-session individual format mindfulness intervention. Each session 
emphasized mindful awareness of breath, body, and thoughts, and involved child and 
parent participation. An additional twelve children were randomized to either an 
  vi 
immediate treatment (n = 6) or a waitlist (i.e., delayed treatment; n = 6) condition during 
the course of a randomized waitlist-controlled clinical trial. Measures were administered 
at pre-waitlist (if applicable), post-waitlist/pre-treatment, post-treatment, and eight weeks 
following treatment to assess overall program satisfaction and changes in symptoms and 
diagnosis.  
 Overall, treatment dropout was low, and families reported high satisfaction with 
treatment. Relative to waitlist, children in the immediate treatment group evidenced 
significant difference in mean change scores on Clinical Global Improvement Severity 
score and Child Behavioral Checklist Internalizing and Anxiety Problems scales. Effect 
size statistics indicated very large effect sizes between the waitlist and immediate 
treatment groups for change in GAD Clinical Severity Rating, child self-report of 
worries, and mindfulness ability, despite non-statistical significance.  
Overall, the intervention demonstrated feasibility, acceptability, and preliminary 
evidence of potential efficacy even in this small pilot study. Effect size estimates suggest 
a larger randomized clinical trial is warranted to fully evaluate treatment efficacy.  
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Introduction 
Generalized Anxiety Disorder in Youth 
Generalized Anxiety Disorder (GAD) is one of the most common and impairing 
childhood anxiety disorders. According to the Diagnostic and Statistical Manual of Mental 
Disorders, Fourth Edition, Text Revision (DSM-IV-TR; American Psychiatric Association, 
2000), GAD is characterized by excessive, difficult-to-control anxiety and worry about a 
number of events and activities. This worry must occur for more days than not for a period of 
at least 6 months. In addition, the worry is accompanied by various physiological symptoms, 
such as muscle tension, restlessness/feeling keyed up or on edge, difficulty 
concentrating/mind going blank, being easily fatigued, irritability, and sleep disturbance. In 
children, the diagnosis only requires at least one physiological complaint to be present as 
opposed to at least three symptoms in adults.  
According to epidemiological research, over 10% of children meet criteria for a 
clinical level of GAD, with an average age of onset at 8.5 years (Keeton et al., 2009). 
Anxiety disorders in children have been associated with increased risk for the 
development of additional anxiety and depressive disorders in adolescence and adulthood 
(United States Department of Health, 1999). Children with GAD are also at risk for 
developing academic and social difficulties and, if left untreated, GAD can continue into 
adulthood (Keeton et al., 2009). In fact, 12.8% of adults meet criteria for GAD in their 
lifetime (Ruscio et al., 2007). 
Although worry is a normative part of childhood development, the presence of 
excessive worry may be an indicator of a clinical presentation of GAD. A study 
examining differences between worry in children with GAD and a normative sample 
  
2 
2 
indicated children with GAD report an average of six worries versus the control group, 
which endorsed an average of one worry (Silverman, La Greca, & Wasserstein, 1995). In 
addition, several studies have found that children with GAD endorsed a higher number of 
worries when compared to children with other anxiety disorders; that is, they endorsed 
more domains of worry (Tracey, Chorpita, Douban, & Barlow, 1997; Weems, Silverman, 
& La Greca, 2000). Specifically, Layne, Bernat, Victor, and Bernstein (2009) found that 
children with GAD, when compared to a nonclinical sample of children and children with 
another anxiety disorder, reported higher rates of worry in the domains of health, 
performance, and family. In addition, compared to children without GAD, those with 
GAD endorsed more associated symptoms of worry, such as “restlessness/difficulty 
relaxing” when worrying. Finally, studies have indicated that GAD in childhood is highly 
comorbid with other disorders; specifically, other anxiety and depressive disorders 
(Layne, Bernat, Victor & Bernstein, 2009; Masi et al., 2004). 
Potential for Mindfulness Treatments  
GAD, both in youth and adults, is characterized by excessive worry in a number 
of domains including school or work performance, health and safety of self and others, 
world affairs, and future events. Indeed, given the future-oriented, ruminative focus of 
individuals with GAD, mindfulness may be an effective strategy for these individuals to 
use. Roemer and Orsillo (2002) posit that practicing awareness of the present moment 
helps patients with GAD to recognize anxious feelings and monitor coping strategies 
while disengaging focus from future-oriented worries.    
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Given that cognitive patterns established in childhood may persist into adulthood, 
the development of a mindfulness-based treatment for chronic anxiety may be 
particularly beneficial for this childhood population. Mindfulness skills can teach 
children a more flexible way of thinking and viewing the world. Thus, mindfulness 
interventions can provide children additional coping skills that may have positive-long 
term impact for a child’s overall functioning. Mindfulness is an element of Buddhist 
meditation in which one practices focused, non-judging attention in the present moment. 
As Kabat-Zinn (1994) writes, “mindfulness means paying attention in a particular way: 
on purpose, in the present moment, and nonjudgmentally…this kind of attention nurtures 
greater awareness, clarity, and acceptance of present-moment reality” (p. 4). In other 
words, mindfulness is defined as having a nonjudgmental awareness and attention to the 
present and can be achieved through the practice of mindfulness meditation as well as 
other practices. Through mindfulness, one can learn to be open and accepting of one’s 
thoughts, both positive and negative, on a moment-to-moment basis. In addition to 
accepting one’s thoughts, mindfulness encourages a focus on internal sensations and 
emotions and external stimuli.  
A growing body of research has shown that mindfulness interventions may be 
efficacious in reducing symptoms among adults across a range of problems and disorders 
including chronic pain (Kabat-Zinn, 1982; Reibel et al., 2001), anxiety (Kabat-Zinn et al., 
1992), depression (Segal et al., 2002; Teasdale et al., 2000), post-traumatic stress disorder 
(Wolfsdorf & Zlotnick, 2001), and eating disorders (Kristeller & Hallett, 1999).  
Mindfulness-Based Stress Reduction (MBSR) was developed by Kabat-Zinn 
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(1982) in a behavioral medicine setting to target patients with chronic pain or stress-
related disorders. MBSR was designed as a group intervention conducted over 8-10 
weeks and mindfulness exercises emphasized focusing attention on a particular target, 
such as one’s breathing. Several studies have shown that MBSR improves ratings of pain, 
and that these improvement ratings were maintained at follow-up (Kabat-Zinn, 1982; 
Kabat-Zinn et al., 1985; 1987). MBSR has also been shown to reduce symptoms in adults 
with binge-eating, (Kristeller & Hallett, 1999), generalized anxiety and panic disorders 
(Kabat-Zinn et al., 1992) in open trials. However, because these did not include control 
groups, there is a clear need for more rigorous research examining mindfulness-based 
treatments as compared to control groups, such as treatment as usual.  
Mindfulness-Based Cognitive Therapy (MBCT) was developed by Segal and 
colleagues (2002) and integrates mindfulness techniques with cognitive-behavioral 
therapy components. MBCT was initially developed as an 8-week group intervention to 
prevent relapse of major depression in adults (Teasdale et al., 1995). Indeed, Teasdale 
and colleagues (2000) conducted a randomized controlled trial and found that MBCT 
significantly reduced rates of relapse of recurrent depression in adults. It has been 
suggested that the process of examining thoughts in a nonjudgmental way may interrupt 
the ruminative cognitive pattern that can be common for individuals with depression 
(Teasdale, 1999; Teasdale et al., 1995).  
Moreover, a growing body of research suggests that mindfulness-based treatment 
is efficacious in reducing anxiety symptoms in adults with GAD (Evans et al., 2008; 
Craigie et al., 2008; Roemer et al., 2008). Specifically, Roemer and colleagues (2008) 
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conducted a randomized controlled trial examining a mindfulness-based behavioral 
therapy for adults with GAD compared to a waitlist control group. Patients were seen 
individually over 16 sessions. Results indicated that, compared to the control group, 
patients reported significantly reduced GAD and depressive symptoms, both on clinician-
rated and self-rated measures, at both 3- and 9-month follow-up evaluations. While 
treatments incorporating mindfulness techniques have been shown to be efficacious in the 
adult literature, to date, relatively few studies have examined the efficacy of these 
techniques in the treatment of children.  
Applications of Mindfulness Treatments for Childhood Anxiety Disorders 
Although cognitive-behavioral treatment (CBT) research suggests that 60-90% of 
children report a reduction in clinically significant anxiety symptoms (Barrett et al., 
2001), little is known about the 10-30% of children who do not respond to traditional 
CBT. While studies have shown that CBT is effective in reducing GAD symptoms, 
approximately 50% of children still report clinically significant GAD symptoms after 
treatment (Payne, Bolton, & Perrin, 2010). Moreover, most studies evaluate the treatment 
of GAD among other anxiety disorders and, to date, few have specifically focused on 
GAD (Suveg et al., 2009). Thus, mindfulness treatment research for children diagnosed 
with GAD fills an important gap.   
Preliminary evidence for childhood mindfulness-based treatments for anxiety is 
promising (see Table 1). Liehr and Diaz (2010) conducted a pilot study comparing a 
mindfulness intervention to a health education intervention in 18 children ages 7-12 with 
depressive and anxiety symptoms, in which more than half of the sample were children 
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from Caribbean and Central American countries. Children were randomly assigned to an 
intervention group. The mindfulness intervention curriculum was designed by 
Mindfulschools.org and focused on teaching mindful awareness to breath, body, 
movement, and generosity. The health education intervention consisted of educating 
children regarding the importance of activity, eating healthy, and stress management. 
Both interventions consisted of ten 15-minute classes conducted daily for 2 weeks. 
Results indicated that children in the mindfulness intervention group reported lower 
levels of both depressive and anxiety symptoms post-treatment when compared to 
children in the health education intervention group. Although the study included a small 
sample size and a non-clinical sample, it provides promise for the use of mindfulness 
skills in reducing anxiety symptoms in children. 
Biegel, Brown, Shapiro, and Schubert (2009) conducted a randomized clinical 
trial comparing MBSR to treatment as usual in adolescents (ages 14-18) recruited from a 
hospital child and adolescent outpatient clinic. The MBSR intervention consisted of eight 
weekly classes focused on formal mindfulness practices such as body scan, sitting and 
walking meditations, and Hatha yoga. The MBSR program was adapted to be 
developmentally appropriate for adolescents so meditation practices were shortened from 
45 minutes to 20-30 minutes in length and the daylong retreat was removed from the 
program. Prior to treatment randomization, youth were identified as having a mood 
disorder (n = 50), anxiety disorder (n = 31), and other disorder (n = 25) using DSM-IV 
criteria, although a clinician-rated clinical interview was not conducted and no 
information was provided on specific diagnoses. At post-treatment, participants in the 
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MBSR condition, compared the control group, reported significantly lower levels of 
depressive, anxiety, and somatization symptoms. While this study provides support for 
using mindfulness interventions in treating youth anxiety, the sample included youth with 
a range of diagnoses, making it difficult to generalize these findings to youth with a 
specific primary anxiety diagnosis.  
Semple, Reid, and Miller (2005) conducted an open trial examining the feasibility 
and acceptability of a downward adaptation of MBCT for children with anxiety (MBCT-
C). MBCT-C includes several modified components of MBCT for adults in order to 
consider developmental limitations, including children’s limited capacity for attention 
and abstract thinking. In order to address these issues, MBCT-C was designed as a 6-
week school-based intervention conducted to a group of five children ages 7-8, and 
included exercises incorporating different senses, such as seeing and hearing. In 
examining open-ended responses from a parent questionnaire, results of their study 
provided preliminary indication that the children were able to understand the concept of 
mindfulness and practice mindfulness techniques taught during the intervention. 
However, Semple and colleagues did not formally measure degree of change in 
mindfulness ability in these children. Lee, Semple, Rosa, and Miller (2008) built upon 
Semple and colleagues’ pilot data by testing the feasibility and acceptability of MBCT-C 
for internalizing and externalizing symptoms in children. In this study, MBCT-C was 
administered in a group format over a 12-week period for twenty-five children ages 9-12, 
with six or seven children in each group. Results indicated a reduction in internalizing 
and externalizing symptoms on a parent report measure. However, there was no 
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significant change in anxiety on a child self-report measure. Moreover, the authors note 
that prior to treatment, children exhibited subclinical levels of internalizing and 
externalizing symptoms, contributing to a floor effect and, therefore, limiting the 
generalizability of the findings. Finally, Semple, Lee, Rosa, and Miller (2010) expanded 
upon their previous work by conducting a small randomized trial of MBCT-C for inner-
city children struggling with academic problems. Specifically, an education psychologist 
referred children having reading difficulties to the program. In addition, twenty-one of 
the 25 children were ethnic minorities. Although results indicated a decrease in child self-
report and parent report of anxiety symptoms, similar to their previous studies, Semple 
and colleagues did not use any clinician-rated measures of anxiety and children did not 
report clinically elevated anxiety symptoms prior to treatment. Although showing 
promise for the feasibility and acceptability of MBCT-C with ethnically diverse children, 
there were several limitations in these studies. First, in both studies, MBCT-C was 
delivered to a nonclinical sample of children, restricting the range and severity on 
outcome measures. As Lee and colleagues (2008) noted, because children initially 
reported sub-clinical levels of anxiety, it was more difficult to measure symptom change 
over time. Second, study outcomes were assessed only through child self-report and 
parent report measures. There were no clinician-rated measures of symptom outcome. 
Third, Lee and colleagues did not compare their treatment to a control condition, thereby 
limiting the conclusions that can be drawn, specifically, whether the treatment was 
responsible for symptom change over time. Moreover, while Semple and colleagues did 
compare MBCT-C to a control group, results indicated that comparable improvements in 
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anxiety symptoms were reported across groups and therefore the intervention could not 
be attributed as the sole cause of anxiety reduction. Further research is clearly needed to 
examine whether MBCT-C and other mindfulness-based interventions are efficacious for 
children with elevated anxiety symptoms and for those with specific childhood anxiety 
disorders, such as GAD.  
Cognitive Development and Metacognition 
It has been suggested that two cognitive abilities are needed in order for an 
individual to have the capability to worry (Vasey, 1993): (1) the ability to anticipate 
future events and (2) the ability to go beyond is what is observable to predict catastrophic 
outcomes. According to Piaget’s (1970) model of cognitive development, middle 
childhood is a developmental period in which children start to form more complex ideas 
about the future and can ruminate on different possibilities for a given event or situation. 
In fact, a study by Muris and colleagues (2002) examining the relationship between 
anxiety and cognitive development in children ages 4-13 found that although children at 
all ages reported fears and worries, they became more frequent as children passed the 
conservation task, which occurs during Piaget’s Concrete Operational Stage, between the 
ages of 7 and 11. This finding suggests that as cognitive maturation increases, children 
have increased ability to predict and expand upon possible threatening outcomes. 
 Along with cognitive maturation, children begin to develop the ability for 
metacognitive thinking (Kuhn, 1999). The concept of metacognition was first formulated 
by Flavell (1979) and is often defined as “thinking about thinking.” Wells (2004) defined 
metacognition as “the cognitive processes, strategies, and knowledge that are involved in 
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the regulation and appraisal of thinking itself” (p. 167). More specifically, Brown and 
colleagues (1983) defined metacognition broadly to include: (1) introspective knowledge 
about one’s cognitive states and abilities and their operation, (2) the ability to use 
metacognition to achieve goals, and (3) cognitive monitoring of thoughts (i.e., the ability 
to read one’s own mental state). In order words, metacognition is the ability to examine 
your thought processes as a mental activity.  
The Metacognitive Model, GAD, and Mindfulness Treatments 
Research has shown that mindfulness-based treatment with adults has been 
associated with increases in metacognitive awareness (Teasdale et al., 2002). More 
specifically, research has found that adults with GAD tend to view their worries as 
uncontrollable (Wells, 1995). Wells and Carter (1999, 2001) have developed a 
metacognitive model that explains how beliefs about these worries (worry about worry) 
influence the development and maintenance of anxiety disorders. Specifically, Wells and 
Carter (1999) posit that individuals with GAD “hold rigid positive beliefs about the 
usefulness of worrying as a coping strategy…[and] also hold negative beliefs and 
appraise worrying as uncontrollable and dangerous. This combination of cognitions and 
associated responses leads to an increased frequency and generality of worrying … 
characteristic of GAD” (p. 585). Not only do individuals with GAD hold positive beliefs 
that worrying is a useful coping strategy, these individuals also hold negative beliefs 
regarding worrying at the same time, which posit that worrying is uncontrollable and 
dangerous. Wells posits that these negative beliefs about worry are unique to individuals 
with GAD. In other words, they are also worrying about their worrying, which Wells 
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defines as negative meta-worry. It is this negative meta-worry that is more problematic 
than positive meta-worry, or believing worrying is a useful coping strategy (Wells & 
Carter, 1999). Metacognition, then, could be viewed as both a potential mediating and 
moderating factor in the relationship between treatment and anxiety reduction.  
Research has shown that, compared with younger children, adolescents have 
increased and more advanced metacognitive abilities. (Bacow et al., 2008; Flavell, Green, 
& Flavell, 1998; Ormond et al., 1991). Simons, Schneider and Herpertz-Dahlman (2006) 
conducted a small pilot study examining the effects of Metacognitive Therapy in 
adolescents with Obsessive-Compulsive Disorder (OCD). They found that youth who 
were encouraged to accept their worried thoughts reported a reduction in OCD symptom 
severity. That is, youth were taught to treat their worried thoughts as mental events that 
did not require further processing as opposed to regarding their worried thoughts as fact. 
In this way, they were able to attribute less value to their worry. They were taught to 
simply notice their worried thoughts and then let them go.  
Research examining mindfulness and its relationship with increased 
metacognitive capabilities in children is still emerging and there is partial support for the 
downward extension of the metacognitive model of GAD to children and youth, though 
findings have been mixed when comparing differences in metacognitive ability between 
anxious and non-anxious youth. For example, some studies have found that clinically 
anxious children report more negative beliefs about their worry (negative meta-worry) 
when compared to their normal counterparts (Cartwright-Hatton et al., 2004) while other 
studies have shown that there is no difference (Bacow et al., 2009). Additionally, results 
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have been mixed regarding age and gender differences as well. Specifically, Cartwright-
Hatton and colleagues did not find any age or gender differences, while Bacow and 
colleagues found that adolescents reported greater awareness of their thoughts than 
children and adolescent girls scored higher on the total index scale of the Metacognitions 
Questionnaire for Children (MCQ-C) when compared to adolescent boys. Thus, although 
this research area is young (Ellis & Hudson, 2010), understanding the relationship 
between children’s worry and their metacognitive processes may provide a significant 
contribution to future treatment research. Accordingly, a secondary and exploratory goal 
of this proposal is to further understand the role metacognition may play in the 
relationship between mindfulness abilities and symptoms of GAD in children.  
Present Study 
Therefore, given that initial research in the field has shown promise for 
mindfulness-based interventions developmentally adapted for children, it seems logical as 
a next step to develop a child-focused, individually delivered mindfulness-based 
intervention targeting GAD in a clinical sample of school-aged children. Research 
indicates that interventions for child anxiety disorders can be effectively delivered in both 
individual and group formats. However, an individual-based intervention has a number of 
potential advantages. First, it allows the treatment to be more easily tailored to the child’s 
developmental level. Second, it is likely to enhance portability of the treatment to 
numerous community settings where it may be difficult to coordinate group interventions 
and where individual treatment is the typical format. Third, the effects of individual 
versus group treatments for child anxiety have been shown to be largely equivalent in 
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terms of post-treatment outcome (Liber et al., 2008; Flannery-Schroeder, Choudhury, & 
Kendall, 2005). Finally, research on adult mindfulness- and acceptance-based 
interventions has efficaciously used an individual treatment format (Roemer et al., 2008; 
Roemer & Orsillo, 2007).  Thus, the present study focused on developing a 
developmentally sensitive, individually-delivered mindfulness-based treatment for youth 
with GAD.   
Aims of the Present Study 
Given the promising results of previous mindfulness research for children, the 
current research aimed to evaluate the feasibility, acceptability, and efficacy of a six-
week mindfulness treatment program for GAD for children ages 9 to 12 through 2 
studies. The overall aims of the current study were as follows: 
Aim 1 (Study 1): To gather data on the feasibility and acceptability of the 
intervention and refine the treatment during an open trial pilot testing phase. During this 
phase, 4 children, including 2 girls and 2 boys, and their parents participated in the 
intervention. 
Aim 2 (Study 2): To conduct a small waitlist-controlled trial comparing the newly 
refined intervention to a 6-week waitlist control group; and to assess the feasibility, 
acceptability, and clinical utility of the newly developed intervention. During this phase, 
12 children, including 6 girls and 6 boys, and their parents participated in the 
intervention. 
Aim 3 (Exploratory): To examine the impact of mindfulness strategies on 
children’s metacognitive capacities, specifically the relationship between metacognition, 
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mindfulness ability, and anxiety symptoms. Children’s level of metacognitive ability was 
measured by the Metacognitions Questionnaire for Children (MCQ-C). 
Hypotheses 
The specific hypotheses of the present study are as follows: 
Aim 1, Hypothesis I: Both children and their parents will report high levels of satisfaction 
with the intervention, as measured by a treatment satisfaction questionnaire, indicating 
treatment feasibility and acceptability. 
Aim 2, Hypothesis I: Children receiving the intervention will display significantly greater 
improvements than those in the waitlist condition, as measured by higher CGAS ratings 
and lower GAD severity and greater improvement ratings (CGI-S and CGI-I). 
Aim 2, Hypothesis II: Children receiving the intervention will display significantly 
greater improvements than those in the waitlist condition on secondary measures of child 
symptoms (e.g. parent report of internalizing symptoms, self-report of anxiety), as 
measured by lower scores at post-treatment compared to post-waitlist.  
Aim 2, Hypothesis III: Children will maintain treatment gains as evidenced by secondary 
measures of child symptoms at 8 weeks following intervention completion. 
Aim 2, Hypothesis IV: Children receiving the treatment will display significantly greater 
improvement from pre-treatment to post-treatment as measured by lower severity ratings 
of GAD diagnosis (ADIS-IV-C/P) when compared to children in the waitlist condition 
from pre-waitlist to post-waitlist/pre-treatment. 
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Aim 3, Hypothesis I: Children will show increases in metacognitive awareness at post-
treatment compared to their pre-treatment scores, as measured by the MCQ-C Cognitive 
Monitoring Subscale. 
Aim 3, Hypothesis II: Children will show increases in mindfulness ability at post-
treatment compared to their pre-treatment scores, as measured by the Child Acceptance 
and Mindfulness Measure (CAMM). 
Aim 3, Hypothesis III: Metacognition will be associated with children’s mindfulness 
ability and GAD symptoms at all time points as illustrated through cross-sectional 
analyses in that higher levels of metacognitive abilities, as measured by the Cognitive 
Monitoring subscale of MCQ-C, will be significantly correlated with higher levels of 
mindfulness ability, as measured by the CAMM, at post-treatment and follow-up. In 
addition, we hypothesize that higher levels of mindfulness ability will be associated with 
lower levels of worry, as measured by the PSWQ-C, at post-treatment and follow-up. 
Finally, we hypothesize that following the intervention, children will report less negative 
beliefs about worry (negative meta-worry), as measured by the Negative Beliefs about 
Worry subscale of the MCQ-C.  
Method 
The first step of this project was to develop and manualize a mindfulness-based 
intervention for children using adult mindfulness treatments as a model. Specifically, 
several adaptations were included to ensure that the proposed treatment was 
developmentally sensitive and appropriate for children ages 9-12. Treatment development 
considerations included shorter treatment sessions as compared to adult mindfulness 
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treatments; mindfulness activities that are more concrete and focused on each of the 
senses, including mindful breathing, mindful walking, mindful eating, mindful listening, 
mindful touching, and mindful smelling; and the use of concrete examples and games to 
engage and assist children in understanding the material at an appropriate cognitive level. 
Additionally, parental involvement was encouraged; specific psychoeducational 
components for parents were included, and sessions were designed so that, at the end of 
each session, children were invited to teach their parents the mindfulness exercise learned 
in session. Thus, parents participated with and encouraged the child at home when 
practicing the mindfulness exercises. This was a particularly important component, as 
studies of youth with anxiety disorders indicate that during this developmental period, 
family involvement in treatment may enhance outcomes (Hudson & Rapee, 2005). 
The proposed research occurred over two phases (Study 1 and Study 2). In both 
phases, participants were children between the ages of 9 and 12 years, who experienced 
symptoms associated with GAD, and their parents. In addition, participants were on the 
waitlist for the Child and Adolescent Fear and Anxiety Treatment Program through the 
Center for Anxiety and Related Disorders (CARD) at Boston University. Following an 
initial assessment, participants who meet diagnostic criteria for a principal diagnosis of 
GAD (Clinical Severity Rating [CSR] of 4 or above) were eligible to participate in the 
treatment program. The nature of the intervention and the specific treatment components 
were described to each family prior the initial assessment to ensure each family’s 
motivation for and commitment to a work-intensive, skills-based intervention. 
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Participants 
Approval for this research study was obtained from the human subjects research 
Internal Review Board at Boston University. Sixteen children (aged 9 to 12) with a 
principal diagnosis of GAD were enrolled in the study. Four participated in the open trial 
while twelve were randomized to either the immediate treatment (n = 6) or waitlist (i.e., 
delayed treatment; n = 6) condition. Sixteen participants (n = 4 for the open trial phase, n 
= 6 for immediate, and n = 6 for waitlist condition) entered the treatment phase and 
fifteen participants completed the intervention. The one participant who terminated early 
did so due to maternal health issues after completing three sessions, and post-treatment 
and follow-up data were collected. The study CONSORT diagram highlighting the 
between-subjects design is presented in Figure 1. The mean age of study participants was 
10.44 (SD = 1.09). The sample was primarily Caucasian (87.5 %) and Non-Hispanic 
(100%). 
Children previously enrolled in CBT were eligible to participate as long as the 
generalized anxiety symptoms were still deemed clinically significant (as indicated by a 
clinical severity rating on the Anxiety Disorders Interview Schedule, Child and Parent 
Versions (ADIS-IV-C/P; Silverman & Albano, 1997) of 4 or greater, as described below 
in the Measures section). Participants on psychotropic medication were included if they 
were willing to maintain a constant dose throughout the treatment program and met 
standard Center for Anxiety and Related Disorders (CARD) requirements for medication 
stabilization prior to their initiation of services (described below in detail in the 
Inclusion/Exclusion criteria section). This requirement was instituted to avoid possible 
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confounding effects on outcome of altering medication status during treatment. Three 
participants were concurrently taking psychotropic medications (18.75%), including 
selective serotonin reuptake inhibitors (SSRIs; n = 2; 12.5 %) and stimulants (n = 1; 6.25 
%); in all three cases parents reported that medication and dosage was maintained 
throughout the study. 
Inclusion and exclusion criteria. Selection of our inclusion criteria were designed 
to enhance development of a specific treatment protocol for GAD in late childhood/early 
adolescence and to ensure that medication usage does not threaten our ability to 
determine the impact of our psychosocial intervention. All patients must have met the 
following criteria to be eligible for study participation: (a) The child received a principal 
anxiety disorder diagnosis of GAD assigned at pre-treatment, based on DSM-IV criteria. 
This diagnosis was derived from the Anxiety Disorder Interview Schedule for DSM-IV, 
Child and Parent Versions (ADIS-IV C/P; Silverman & Albano, 1997), and reflected a 
clinical severity rating of 4 or above (see description of ADIS-IV in measures section); 
(b) The child was between the ages of 9 and 12 years; (c) At least one parent or caregiver 
was available to accompany the child to all assessment and treatment sessions; (d) If the 
child was on benzodiazepines, there must be a 1-month stabilization period, and if the 
child was on SSRI’s or Tricyclics, a 3-month stabilization period prior to the initial 
diagnostic assessment (this was a requirement of all children referred to our program and 
reflects a long-standing policy for both adult and child studies of psychological 
treatments). During this stabilization period and throughout the course of the child’s 
participation in the study, the child must have remained on a constant dose of any anti-
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anxiety or anti-depressant medications. If the child was not on medication at the start of 
the study, he or she must have remained off anti-anxiety or anti-depressant medication 
throughout the course of the study. As anticipated, there was a low rate of medication use 
in this age group. To maximize the generalizability of this study, participants were only 
excluded for conditions that would limit their ability to participate in the treatment 
program, or limit our ability to interpret our results. Children with comorbid diagnoses 
were not excluded from the study unless they met any of the following exclusion criteria 
because of the ethical implications of requiring such individuals to refrain from additional 
treatment during the program and the questionable efficacy of providing such individuals 
with abbreviated clinical service duration. Exclusion criteria were: (a) Positive diagnosis 
of pervasive developmental disorder, neurological disease, mental retardation, or current 
suicidal ideation; (b) Positive diagnosis of bipolar disorder or psychotic disorders; (c) 
Anxiety or mood symptoms which appeared to be primarily due to a medical/physical 
condition, as determined through the review of a medical information form and clinical 
interview, because alternative treatment would be clinically indicated; (d) Unavailability 
of at least one parent or caregiver with whom the child is living to bring the child to 
treatment; (e) Refusal of the parent(s) or child to accept stabilization of medication (see 
criterion d in inclusion criteria; in our experience we have never had families refuse to 
accept medication stabilization criteria); (f) Children whose parents presented with any 
condition such as mental retardation, that would limit their ability to read or understand 
the treatment; (g) Children and parent(s) who did not speak English. However, no parents 
were excluded for any of these reasons. Children previously enrolled in a cognitive 
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behavioral treatment at CARD or elsewhere were eligible to participate as long as the 
GAD symptoms were still deemed clinically significant (indicated by a GAD diagnosis 
with a severity rating in the clinical range). If needed, permission was obtained to contact 
any previous clinician where the latter criteria were unclear. However, participants who 
were seeking any additional type of psychosocial treatment agreed to refrain from 
receiving additional psychosocial treatment sessions during the 6-week mindfulness 
treatment in order to measure whether the proposed treatment was responsible for change 
in anxiety symptoms.  
Procedure 
Recruitment of participants. Participants and their parent(s) were recruited 
through referrals to CARD. Informed consent and assent were obtained prior to study 
enrollment.  
Research design. Study 1 was an open trial, including four participants who 
received immediate treatment, while Study 2 utilized a minimal contact waitlist-
controlled trial design with twelve participants recruited and randomized to either the 
immediate treatment (n = 6) or waitlist condition (n = 6). Those randomized to the 
waitlist condition then completed treatment after six weeks. The full assessment battery 
(described below) was administered at pre-treatment/pre-waitlist, post-waitlist (if 
applicable), post-treatment, and eight-weeks following treatment to assess symptom 
change. In addition, at the post-treatment time point, a treatment satisfaction 
questionnaire was administered. Independent Evaluators (IE) conducted all assessments 
after the pre-treatment/pre-waitlist time points. The IEs were advanced graduate students 
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in a clinical psychology Ph.D. program and one Ph.D.-level psychologist who were 
otherwise uninvolved in the study. 
Measures 
Primary Outcome Measures 
Clinician-rated measure of clinical status. The Anxiety Disorders Interview 
Schedule, Child and Parent Versions (ADIS-IV-C/P; Silverman & Albano, 1997) was 
administered during the intake appointment to youth who were referred to CARD for 
diagnosis of DSM-IV anxiety, mood and externalizing disorders of childhood. The child 
was seen first, followed by the parent(s), and composite diagnoses were formed using 
specific guidelines (Silverman & Nelles, 1988). Diagnoses assigned a clinical severity 
rating (CSR) of 4 or above on an 8-point scale, based on a clinician-rated consensus of 
parent and child reports, were considered to be clinical diagnoses. Interrater reliability of 
the ADIS-IV-C/P at CARD was estimated on a weekly basis, and the ADIS-IV-C/P has 
demonstrated good interrater reliability (r = .98 for the ADIS-C; r = .93 for the ADIS-P) 
and test-retest reliability (k = .76 for ADIS-C; k = .67 for ADIS-P; Silverman & Eisen, 
1992; Silverman et al., 1988). Children recruited from CARD were offered participation 
in the study if they had a diagnosis of GAD at a clinical level of severity (i.e. CSR of 4 or 
higher). While the full ADIS-IV-C/P was used in the present study during the intake 
assessment, a shorter version (Mini ADIS-IV-C/P) was administered to children and their 
parents at the post-waitlist (if applicable), post-treatment, and follow-up assessment 
points. The Mini-ADIS-IV-C/P contains select subsections of the ADIS-IV-C/P and takes 
approximately one hour to administer, whereas the complete ADIS-IV-C/P takes 
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approximately three hours. 
Measure of functional impairment. Overall improvement and functional 
impairment was measured using the Children’s Global Assessment Scale (CGAS; 
Schaffer et al., 1983). The CGAS assesses overall general functioning for a specified time 
period by selecting the lowest level which describes the child’s functioning on a 
continuum of health-illness on a 100-point scale. CGAS score ranges are as follows: 100-
91 indicates “superior functioning,” 90-81 indicates “good functioning in all areas,” 80-
71 indicates “no more than slight impairment in functioning,” 70-61 indicates “some 
difficulty in a single area but generally functioning pretty well,” 60-51 indicates “variable 
functioning with sporadic difficulties or symptoms in several but not all social areas,” 50-
41 indicates “moderate degree of interference in functioning in most social areas or 
severe impairment of functioning in one area,” 40-31 indicates “major impairment in 
functioning in several areas and unable to function in one of these areas,” 30-21 indicates 
“unable to function in almost all areas,” 20-11 indicates “needs considerable 
supervision,” and 10-1 indicates “needs constant supervision.” The CGAS was completed 
by the clinician only and higher ratings indicate more superior functioning. Studies have 
used a cut-off score of  > 70 to indicate a “non-case” meaning not clinical (Schorre & 
Vandvik, 2004).  
Global severity/improvement. Overall severity and improvement was measured 
using the Clinical Global Impression Scale (CGI; Guy, 1976). The CGI assesses overall 
clinical severity (CGI-S) and improvement (CGI-I), each on a 7-point scale (lower values 
reflect lower severity and greater improvement). At pre-treatment, only severity was 
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rated, and in later assessments both severity and improvement were rated. CGI is 
frequently used in clinical trials to evaluate outcome. Scores of 1(very much) or 2 (much) 
on improvement and/or < 3 (borderline to not at all ill) on severity are typically 
considered acceptable response to acute treatment.  
Child report measure of worry. The Penn State Worry Questionnaire for Children 
(PSWQ-C; Chorpita et al., 1997) is a 14-item self-report measure that assesses degree of 
excessive, generalized, and uncontrollable worry in children and adolescents. A total 
score is computed ranging between 0 and 42, with higher scores reflecting a stronger 
tendency to worry. Raw scores are then converted to T-scores (M = 50, SD = 10). The 
PSWQ-C has demonstrated good psychometric properties, including high internal 
consistency, high convergent validity, good discriminant validity, and excellent reliability 
in a clinical sample (Chorpita et al., 1997; Pestle, Chorpita, & Schiffman, 2008). 
Secondary Outcome Measures 
Parent report of internalizing symptoms. The Child Behavior Checklist (CBCL; 
Achenbach & Edelbrock, 1983) is a 113-item parental report measure designed to assess 
a broad range of children’s and adolescents’ behavioral and emotional functioning. In 
addition to Internalizing, Externalizing, and Total Problems scales, this questionnaire 
measures the following syndromes: Anxious/Depressed, Attention Problems, Rule-
Breaking Behavior, Social Problems, Somatic Complaints, Thought Problems, and 
Withdrawn/Depressed. The CBCL also has six DSM-oriented scales: Affective Problems, 
Anxiety Problems, Somatic Problems, Attention-Deficit/Hyperactivity Problems, 
Oppositional Defiant Problems, and Conduct Problems. It has demonstrated high test-
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retest reliability and been shown to distinguish between clinical and non-clinical samples 
of adolescents (Achenbach & Edelbrock, 1979; Cohen et al., 1985). Raw scores are 
converted to T-scores (M = 50, SD = 10), based on a standardization sample of 2,630 
children between the ages of 4 and 18. The CBCL is a well-standardized measure with 
good reliability and validity (Achenbach, 1991). The following CBCL scales were used 
in the current study: Internalizing and Anxiety Problems. 
Child report measure of anxiety. The Multidimensional Anxiety Scale for 
Children (MASC; March et al., 1997) is a self-report measure that assesses symptoms of 
anxiety in children ages 8-18. The MASC consists of 39 anxiety-related statements and 
yields four scales: Physical Symptoms, Harm Avoidance, Social Anxiety, and 
Separation/Panic. Raw scores are converted to T-scores (M = 50, SD = 10), based on a 
standardized sample of 2,638 children between the ages of 8 and 19. The MASC has 
shown robust psychometric properties in clinical, epidemiological and treatment studies. 
Three-week test-retest reliability for the MASC is 0.79 in clinical samples and 0.88 in 
school-based samples (March et al., 1997). 
Child report of metacognition. The Metacognitions Questionnaire for Children 
(MCQ-C; Landon, Pincus, Ehrenreich, & Brody, 2009) is a recently developed self-report 
measure of metacognition in children and adolescents ages 7 to 17. The MCQ-C consists 
of 24 questions that measure four metacognitive processes: (1) positive meta-worry (or 
positive beliefs about worry, such as “If I worry about things now, I will have fewer 
problems in the future”); (2) negative meta-worry (or negative beliefs about worry, such 
as “If I worry a lot, I could make myself sick”); (3) superstitious, punishment and 
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responsibility (SPR) beliefs (such as “If I couldn’t be in control of what I think, I would 
fall apart”); and (4) cognitive monitoring (or awareness of one’s thoughts, such as “I pay 
a lot of attention to the way that I think”). The MCQ-C total score ranges from 24 to 96 
by summing the scores of all items. Subscale scores are obtained by adding up each item 
in a particular scale. Higher scores on the total scale is evidence of greater levels of 
general metacognitive awareness and processes. Because of the recent development of 
the MCQ-C, there is limited data on its psychometric properties, including reliability and 
validity. The MCQ-C was adapted from the adolescent version (MCQ-A; Cartwright-
Hatton et al., 2004) to be used for both children and adolescents. Bacow and colleagues 
provided preliminary data on internal consistency for the total scale and the four 
subscales, with coefficient alphas of 0.87 for the total scale; 0.86 for Positive Meta-
Worry; 0.75 for Negative Meta-Worry; 0.75 for Cognitive Monitoring; and 0.64 for 
Superstition, Punishment, and Responsibility Beliefs. For the clinical sample, which 
included youth ages 7-17 with a primary anxiety diagnosis, coefficient alphas were 0.89 
for the total scale, 0.89 for Positive Meta-Worry, 0.74 for the Negative Meta-Worry, 0.69 
for SPR Beliefs, and 0.75 for Cognitive Monitoring. The MCQ-C also demonstrated 
some concurrent validity in that the measure was found to be positively correlated with 
the PSWQ-C. However, Bacow and colleagues were unable to demonstrate adequate 
criterion validity on this measure given that they found non-anxious children scored 
higher on cognitive monitoring than children diagnosed with anxiety disorders. Another 
study by Smith and Hudson (2013), also using the MCQ-C measure, found that children 
with and without anxiety reported similar number of superstition, punishment and 
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responsibility beliefs and a similar level of cognitive monitoring. Although this study 
found that cognitive monitoring was positively associated with anxiety symptoms, the 
authors noted that this scale does not necessarily aim to distinguish monitoring of anxious 
or intrusive thoughts, but rather just the ability to monitor and report on their thoughts. 
Thus, the cognitive monitoring scale may be a measurement for general metacognitive 
awareness. On the other hand, Smith and colleagues found that the MCQ-C demonstrated 
criterion validity in that clinically anxious children scored higher on both positive and 
negative meta-worry beliefs than non-clinically anxious children. For the current study, 
we were most interested in the Cognitive Monitoring and Negative Meta-Worry 
subscales. 
Child report of mindfulness ability. The Multidimensional Anxiety Scale for 
Children (MASC; March et al., 1997) is a self-report measure that assesses symptoms of 
anxiety in children ages 8-18. The MASC consists of 39 anxiety-related statements and 
yields four scales: Physical Symptoms, Harm Avoidance, Social Anxiety, and 
Separation/Panic. Raw scores are converted to T-scores (M = 50, SD = 10), based on a 
standardized sample of 2,638 children between the ages of 8 and 19. The MASC has 
shown robust psychometric properties in clinical, epidemiological and treatment studies. 
Three-week test-retest reliability for the MASC is 0.79 in clinical samples and 0.88 in 
school-based samples (March et al., 1997). 
Treatment Satisfaction 
Treatment Satisfaction. Parent- and child-rated satisfaction with the treatment 
program was assessed using a treatment evaluation measure that was created by the PI. 
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See Appendix B for the measure. The measure has a total of 12 items using a 5-point 
Likert scale. Items 1-12 assess how helpful they thought treatment was, how satisfied 
they were with the treatment, and how useful learning the mindfulness skills were. Item 
11 assesses whether the parent or child felt that the parent’s involvement in treatment was 
inadequate and item 12 assesses the desired level of involvement. Total scores range from 
11-55 when including only items 1-11. In addition to the 12 items, there were additional 
open-ended questions asking for feedback from parents and children assessing factors, 
such as the most and least helpful parts of treatment, any part they would want to change, 
whether the parent wished to be more or less involved in treatment, and a space for any 
other feedback. There were high correlations between parent and child report on items 
assessing whether the child’s anxiety improved (r = .71, p = 002) and recommending the 
treatment to others (r = .53, p = 036). 
Intervention Phase 
 Following the pre-treatment/post-waitlist assessment, participants entered the 
intervention phase. All treatment sessions were conducted by Priscilla Chan (PI; principal 
investigator). All sessions were held at Boston University’s CARD. All participants and 
their parent(s) were informed that participation was voluntary and that withdrawal from 
the study in no way impacted their future care at CARD or elsewhere. 
Description of the intervention. The AWARE Program (“Approaching Worries 
Actively through Reflection and Experience,” see Appendix A for the manual) utilizes 
empirically-based mindfulness principles for the treatment of anxiety, tailored 
specifically to meet the developmental needs of participants. The essential components of 
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mindfulness used in the current intervention included psychoeducation; awareness to 
breath, body, and thoughts; and relapse prevention. Concrete exercises were used to teach 
mindful awareness of the present moment by utilizing the six senses, such as eating/taste, 
hearing/sound, touching, and movement. Parents were invited at the end of each 
treatment session, so that the child could teach his/her parent the mindfulness skill 
learned. Table 2 outlines session components and activities. 
Total duration of treatment was six sessions over approximately a six-week 
period. The intervention relied on child engagement both in and out of session and 
parental involvement in weekly practices. Each session was structured in the same way 
while allowing the therapist flexibility to adapt session content based on the child’s 
needs. The beginning of each session involved checking in with the child and reviewing 
the mindfulness practice he/she had engaged in during the previous week. The majority 
of the session focused on teaching a new mindfulness skill and allowing time for both the 
therapist and child to engage in in-vivo practice of the skill. The end of session included 
inviting the parent back into session so that the child and therapist could teach the new 
skill to the parent along with assigning mindfulness practice for the upcoming week. In 
addition, time was spent discussing how the mindfulness skills were applicable for each 
child’s anxiety concerns. More specifically, the first session focused on psychoeducation 
including learning about the nature of anxiety, the concept of mindfulness, and teaching 
breath awareness. Sessions two to five focused on learning mindfulness through specific 
concrete exercises focused on the five senses and including mindful eating, listening, 
touching, and movement. The last session focused on termination, reviewing skills 
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learned, and discussing a relapse prevention plan. The PI was the primary therapist and 
supervision was provided by a Ph.D.-level clinician, who co-authored the protocol, as 
needed over the course of the treatment sessions.  
Data Analytic Strategy for Study 1 
 A case-series design was implemented with assessments occurring at pre-
treatment, post-treatment, and eight weeks following treatment to examine symptom 
reduction and maintenance of treatment gains over time.  
Data Analytic Strategy for Study 2 
Outcome variables were first evaluated for normality and the presence of 
univariate outliers. Next, in order to determine the success of randomization, the two 
conditions were compared with respect to demographic variables and pre-treatment/pre-
waitlist outcome measures using t-tests and Fisher’s exact test. 
 The effect of treatment in comparison to waitlist was examined for both primary 
and secondary outcome measures. To do so, we used independent-samples t-tests to 
assess for the effect of treatment condition. For each outcome variable separately, scores 
at post-assessment (i.e., post-treatment for the immediate treatment group and post-
waitlist for the control group) were predicted by treatment condition, with pre-
treatment/pre-waitlist scores included as a covariate. We then compared scores at pre- 
and post-assessment points for each condition using paired samples t-tests.  
 To assess whether treatment gains were maintained over time as well as the 
intervention’s impact on anxiety comorbidity, the data was collapsed across immediate 
treatment and waitlist groups. This pooling of data is consistent with previous clinical 
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trials of both individual (Kendall, 1994; Kendall et al., 1997; Pincus, Ehrenreich-May, 
Whitton, Mattis, & Barlow, 2010) and group (Silverman et al., 1999) CBT child anxiety. 
We then conducted paired t-tests to determine differences between time points across the 
entire sample. 
 To assess treatment satisfaction across all participants in both Study 1 and Study 
2, a mean satisfaction score was computed using the Treatment Satisfaction Measure. 
Finally, to assess the changes in functional impairment over time, we conducted paired-
samples t-tests on the CGAS using the full sample.  
 Missing data existed across assessments points. Given the preliminary nature of 
the current study and the small sample size, we have chosen to keep the missing data as 
“missing” and use available data for analyses, resulting in different n’s per analysis. We 
have declined to use the intent-to-treat design or data imputation methods, such as last 
observation carried forward, which is common for clinical trials, given that it would have 
skewed the data analysis and interpretation causing to misleading results (Mazumdar, 
Liu, Houck, & Reynolds, 1999).  
Results 
Study 1 
 The mindfulness treatment program was pilot tested on four participants, aged 9 
to 11, each with a principal diagnosis of GAD. All four participants were Caucasian and 
none were taking any psychotropic medication during treatment. Two participants had 
received previous psychological treatment; however, all participants met clinical 
diagnostic criteria for GAD prior to enrollment in the study. First, changes in diagnostic 
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status will be discussed, including comorbid diagnoses. Second, changes in functional 
impairment as measured by the CGAS, CGI-S, and CGI-I scores will be discussed. Third, 
changes in parent- and child-report of anxiety symptomatology as measured by the CBCL 
Internalizing and Anxiety Problems subscales and PSWQ-C and MASC total scores will 
be reviewed. Fourth, changes in mindfulness ability and metacognitive level from pre- to 
post-treatment will be examined. Fifth, a qualitative description of each participant’s 
clinical presentation and treatment outcome will be presented. 
Diagnostic Status 
Table 3 displays the diagnostic status of each participant at pre- and post-
treatment and at an 8-week follow-up. Treatment gains were evidenced through changes 
in diagnostic status across all participants. At post-treatment, three participants no longer 
met clinical criteria for a diagnosis of GAD and by follow-up, all four participants no 
longer met criteria for a clinical diagnosis of GAD. Although not specifically targeted 
during treatment, reductions in severity of comorbid diagnoses were observed and by 
follow-up, only one participant met criteria for a clinical-level diagnosis. 
Functional Impairment, Clinical Global Severity, and Clinical Global 
Improvement  
Table 4 displays each participant’s CGAS score as well as the CGI-S and CGI-I scores 
across all three time points. Three participants’ CGAS scores improved following the 
intervention and at the follow-up, while one participant’s score remained relatively 
consistent. It was this participant who continued to meet clinical diagnostic criteria for 
Social Phobia at post-treatment and follow-up, although he no longer met clinical 
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diagnostic criteria for GAD at the same assessment points. Similarly, the same three 
participants showed improvements in overall clinical severity (CGI-S) and improvement 
(CGI-I) scores while the other participant’s scores did not change over time.  
Child and Parent-Report of Anxiety Symptomatology 
Table 5 outlines changes in T-scores on the CBCL Internalizing and Anxiety 
Problems subscale, PSWQ-C, and MASC Total scale across all three time points. All four 
participants had pre-treatment CBCL Internalizing and Anxiety Problems subscale T-
scores in the clinical range and, at the post-treatment, two participants remained at the 
clinical level for both CBCL subscales. By the follow-up assessment, these same 
participants received a borderline clinical T-score on both CBCL subscales. The other 
two participants had T-scores in the normative range.  
 On the PSWQ-C, one participant had a T-score in the clinical range and one 
participant had a T-score in the high average range, while the other two children reported 
scores in the normative range at pre-treatment. At post-treatment, all children reported 
scores in the normative range, which were maintained at follow-up.  
 On the MASC, three participants reported scores in the normative range at pre-
treatment, which were maintained at the post-treatment and follow-up assessments. One 
participant reported a pre-treatment score in the high average range, which maintained 
throughout the remaining assessment points. 
Child Report of Mindfulness Ability and Metacognition Awareness 
Table 6 outlines changes in total scores on the CAMM and MCQ-C across all 
three time points. Regarding the CAMM, three participants’ total scores remained 
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relatively consistent over the three assessments while one participant showed increases in 
total score, possibly indicating increases in mindfulness awareness. Similarly, all four 
participants’ total scores on the MCQ-C remained relatively consistent. Of note, as 
discussed previously regarding the metacognitive model of GAD, three participants’ 
score on the Negative Meta-Worry subscale (see Table 7) decreased over time, possibly 
indicating decreases in negative beliefs of worry, which typically distinguish people with 
GAD compared to other anxiety disorders. One participant’s negative meta-worry 
decreased at post-treatment, but increased at the follow-up.  
Qualitative Description, Treatment Course, and Outcome by Participant 
 Participant 1. Participant 1 was an 11-year-old Caucasian female who was 
assigned a principal diagnosis of GAD (CSR = 6). Prior to treatment, Participant 1 
worried about doing well in school, small events that happened in the past, being perfect, 
the health and safety of her family members, and general events going on in the world. 
For example, she worried about doing well in school despite receiving positive feedback 
from teachers. She also worried significantly about her mother’s health and safety, often 
asking where her mother would be, or if she would be safe. Additionally, she worried 
about general events in the world, such as having anxiety over the world ending on New 
Year’s Day when she heard about the Mayan calendar prediction of the apocalypse in 
2012. Participant 1 also received a diagnosis of Social Phobia (CSR = 4) at pre-treatment 
to account for her persistent fear of social situations in which she may embarrass herself, 
such as reading aloud in class, starting or joining in on a conversation, using public 
bathrooms, performing in public, speaking to adults she didn’t know well, and attending 
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birthday parties. Participant 1 was an active participant throughout the course of 
treatment, nearly always completing assigned mindfulness practices, only occasionally 
forgetting to complete homework. In addition, her mother was actively involved in 
treatment as well and reported engaging in the mindfulness practice with her daughter 
outside of treatment sessions. Specifically, her mother noted that her daughter “was eager 
to the try the exercises at home and school and was very comfortable talking about her 
[anxiety].” Participant 1 reported enjoying mindful breathing and touching, but also noted 
that she had a difficult time engaging in the skills even when she was worried, 
particularly after school when waiting for her mother or babysitter. She noted that 
mindful listening was more difficult because she could get more easily distracted and be 
unfocused. Finally, her mother noted that the 6 week timeframe was short and expected 
her daughter may need additional time in therapy. Immediately following treatment, 
Participant 1 continued to meet criteria for a clinical diagnosis of GAD although she had 
shown some improvement with a reduction of her CSR to a 5. Although both she and her 
mother reported some reduction in anxiety symptoms and her distress associated with 
them, Participant 1 continued to have the same domains of worry. Additionally, 
Participant 1 continued to meet criteria for Social Phobia (CSR = 4), which was not 
specifically targeted during treatment. From pre- to post-treatment, Participant 1’s CBCL 
score in the Anxiety Problems T-score decreased from 73 (>97th percentile, clinical 
range) to 59 (81st percentile). By follow-up, Participant 1 no longer met clinical criteria 
for GAD (CSR = 2) or Social Phobia (CSR = 3) and her CBCL Anxiety Problems T-
score was a 51 (54th percentile). 
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 Participant 2. Participant 2 was a 9-year-old Caucasian male who was assigned a 
co-principal diagnosis of GAD (CSR = 6) and Social Phobia (CSR = 6). Prior to 
treatment, Participant 2 reported worrying about doing well in school, performing in 
sports, and being perfect. For example, he had a difficult time starting school assignments 
or participating in activities because he did not want to make any mistakes. 
Consequently, he often did not attempt homework or engage in sports. Additionally, 
Participant 2 worried significantly about reading out loud in class, participating in gym 
class, performing in front of others, speaking to adults, and attending social events. 
Participant 2 was a reluctant participant in treatment and often had a difficult time 
reporting on the content of his worries. In addition, Participant 2 had a challenging time 
understanding parts of mindfulness due to the abstract nature of the concept despite 
concrete skills being taught. Because of this, his father was usually present during the full 
session instead of joining at the end. Participant 2’s father actively tried to engage his son 
in using the mindfulness skills outside of sessions, however, Participant 2 reported 
frustration on several occasions and his father stated that, at times, Participant 2 would 
refuse practicing the skills. As a result, one to two sessions included breaking protocol 
and teaching Participant 2 and his father traditional cognitive-behavioral skills, such as 
cognitive restructuring and the concept of exposures. In particular, his father noted that 
his son “shuts down [when anxious] and the [mindfulness] program allowed [them] to go 
at their own pace.” Overall, participant 2’s parents felt like that program helped them to 
understand their son better and become more patient with him during times of anxiety. 
Immediately following treatment, Participant 2 continued to meet criteria for a clinical 
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diagnosis of Social Phobia (CSR = 6) although his GAD CSR had reduced to a 3, 
indicating a subclinical diagnosis. It is unclear whether his reduction in GAD CSR may 
be partly due to the CBT skills also introduced into the treatment. From pre- to post-
treatment, Participant 2’s CBCL score in the Anxiety Problems T-score decreased from 
73 (>97th percentile, clinical range) to 70 (>97th percentile), however; both scores 
remained in the clinical range. By follow-up, Participant 2’s GAD CSR decreased to a 2 
while his Social Phobia CSR remained the same. His follow-up CBCL Anxiety Problems 
T-score decreased to 68 (97th percentile), which is in the borderline clinical range.  
 Participant 3. This participant was a 10-year-old Caucasian female assigned a 
principal diagnosis of GAD (CSR=4). Participant 3 reported experiencing worry and 
stress, although at the pre-treatment assessment, she had a difficult time articulating any 
specific worries. However, she was able to describe the physiological symptoms 
associated with her anxiety as inclusive of nausea, shakiness, dizziness, grumpiness and 
feeling overwhelmed. Participant 3 described her worries as most common on stressful 
school days and, in particular, when she has a large amount of schoolwork to complete. 
Her worries generally focused on school, homework, and feeling overwhelmed. 
Participant 3 also reported being nervous to talk about new things and new changes. 
Although Participant 3 was actively engaged in treatment, she did not want to practice the 
skills with her mother. She was reluctant to have her mother join in for the last 10-15 
minutes of each session. Her mother wanted to respect her daughter’s decision and so did 
not try to practice the skills together with her daughter. Participant 3 reported consistently 
practicing the skills. Participant 3’s mother noted that although her daughter was able to 
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learn the skills effectively, it was harder for her to make the connection between the skills 
and using them for coping strategies. Following the intervention, Participant 3’s 
generalized anxiety symptoms were no longer deemed clinically interfering (CSR=3), 
although based on parent-report, her CBCL Anxiety Problems T-score of 70 (>97th 
percentile) remained in the clinical range (pre-treatment T-score of 72; >97th percentile). 
By follow-up, her GAD CSR remained consistent and her CBCL Anxiety Problems T-
score decreased to a 67 (96th percentile). 
 Participant 4. Participant 4 was a 10-year-old Caucasian male given a principal of 
GAD (CSR=6). Participant 4 reported that he experienced worries about death and 
worrying about family members dying. In addition, he worried about his health and the 
health of his family members; specifically, worrying about contracting illnesses, such as 
cancer. Lastly, he worried about current events, such as the energy crisis. His parents 
reported that they were unable to watch the news because of his anxieties. Participant 4 
experienced a number of physical symptoms when worried, such as fatigue, headaches, 
stomachaches, inability to sit still, weakness in his legs, difficulty concentrating, and 
trouble sleeping. Participant 4 was also given secondary diagnoses of Social Phobia 
(CSR=4) and Specific Phobia (CSR=4) of thunderstorms. Participant 4 was both an 
active and compliant participant throughout the course of treatment, always completing 
assigned mindfulness tasks outside of session. In addition, his mother was consistently 
active in engaging and participating in the skills with her son. In particular, Participant 
4’s mother was familiar with mindfulness and was eager to learn about the skills as much 
as her son, which was a notable feature when compared to the other pilot families. 
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Specifically, Participant 4’s mother reported that she felt like the program gave them 
hope and she walked away with “valuable information and tools.” In addition, Participant 
4 stated he felt the program was “fun and helped his anxiety.” Following the intervention, 
Participant 4 demonstrated notable reductions in his generalized anxiety symptoms, 
which dropped four CSR points, and his secondary anxiety diagnoses, which both 
dropped two CSR points. At the follow-up, he was given a CSR of 1 on both GAD and 
Social Phobia and a CSR of 2 for his Specific Phobia diagnosis. From pre- to post-
treatment, Participant 4’s CBCL score in the Anxiety Problems T-score decreased from 
72 (>97th percentile, clinical range) to 55 (69th percentile) into the normative range, while 
from post-treatment to follow-up, his score dropped to a 51 (54th percentile).  
Treatment Satisfaction 
Parent- and child-rated satisfaction was assessed using the Treatment Satisfaction 
measure. Across the 11 items, parents reported a high level of treatment satisfaction on 
the 1-5 Likert scale (M = 4.16, SD = .66) in addition to children rating high satisfaction 
((M = 4.08, SD = 1.06). In addition, qualitative responses provided further support for the 
intervention. Comments included, “[Treatment was] caring, well paced, descriptive, and 
very supportive. [Parental] involvement was perfect [for my child] and all the family.” 
Another parent noted, “What was most helpful about the treatment was the supportive, 
nonjudgmental approach. Things were explained in a way [my child] could understand 
without being condescending.” Another parent reported, “[It was a] great experience for 
each of us. We both learned a lot.” One child commented, “I learned to stay in the 
moment which kept my mind from wandering off and worrying. I found [the treatment] 
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helpful. I think my mom was involved the right amount. I liked being able to practice 
with her sometimes.” Another child noted, “It was fun and helped my anxiety.”  
Summary of Study 1 
Results from the pilot testing phase suggest school-aged children with GAD 
generally responded positively to the brief 6-week mindfulness intervention. From pre-
treatment to post-treatment and 8-week follow-up points, children showed improvements 
in GAD severity and related anxiety symptomatology, as well as high levels of treatment 
satisfaction. Treatment gains appeared to strengthen over time so that by the 8-week 
follow-up point, all four pilot cases no longer met clinical criteria for GAD as assessed by 
the ADIS-IV-C/P. Furthermore, this pilot testing phase provided strong evidence of 
treatment feasibility and acceptability as shown by the fact that all four families 
completed treatment and positively rated the treatment and outcomes. One clinical 
observation is that children seemed to have more success in treatment when parents were 
highly involved and supportive both during session and outside of sessions.  
Study 2 
After the open trial pilot testing phase, we conducted a small randomized waitlist-
controlled clinical trial with twelve children. Participants were randomized to either the 
immediate treatment (n = 6) or waitlist condition (n = 6). Those randomized to the 
waitlist condition completed treatment after the waitlist period following a post-
waitlist/pre-treatment evaluation (i.e., six weeks after the first evaluation). First, pre-
treatment differences with regard to age, gender, and outcome measures between the 
waitlist and immediate treatment group will be discussed. Second, between group 
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comparisons of change scores between the waitlist group (WL) and immediate treatment 
(IT) group will be discussed. That is, changes in primary outcome measures will be 
reported followed by results in secondary outcome measures. For each set of between 
group analyses, we will present comparisons of change scores for the WL group across 
the waitlist period (i.e., subtracting pre-waitlist scores from post-waitlist/pre-treatment 
scores) and the IT group across the intervention period (i.e., subtracting pre-treatment 
scores from post-treatment scores). Third, these between group comparisons will be 
followed by within group comparisons of changes across treatment by collapsing pre-
treatment and post-treatment data for the total sample. Fourth, associations between 
anxiety symptoms, mindfulness ability, and metacognitive abilities will be presented. 
Preliminary Analyses 
 Given the small sample size, as expected, many variables in the sample evidenced 
non-normality and skewness. Therefore, analyses were run in two ways using the 
Wilcoxon Signed Rank Test and paired-samples t-tests. The results were the same 
between both tests so we have chosen to report analyses using paired-samples t-tests.  
Independent-samples t-tests and Fisher’s exact test were used to assess pre-
treatment differences between the IT and WL groups on demographic and outcome 
variables (see Table 8). Specifically, there was no significant difference in age between 
the IT (M = 10.50, SD = 1.38) and WL groups (M = 10.67, SD = 1.03), t(10) =.24, p = 
.82. Using Fisher’s exact test, there were no significant differences found in gender 
between the IT (50% male) and WL groups (67% male), p = 1.00.  
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 Regarding clinical outcome measures, there were significant pre-treatment 
differences between the IT and WL groups, suggesting higher scores for the IT group 
than the WL group on the MCQ-C total score (M = 50.83, SD = 15.03 versus M = 31.33, 
SD = 5.05, t(10) = -3.01, p = .01), the PSWQ-C total score (M = 67.50, SD = 14.92 
versus M = 43.33, SD = 8.57, t(10) = -3.44, p = .01), and the MASC total score (M = 
56.67, SD = 17.56 versus M = 33.83, SD = 6.85, t(10) = -2.97, p = .01. Overall, the 
children in IT reported higher levels of symptoms that did children in WL on self-report 
measures. No other pre-treatment differences were found. Table 9 shows the means and 
standard deviations of all outcome variables at pre- and post-treatment assessments for 
the IT and WL groups. Table 10 shows the means and standard deviations of all outcome 
variables at each time point for the total combined sample.  
Assessment of Treatment Effects: Primary Outcome Variables 
Independent-samples t-tests were conducted to compare between group 
differences regarding the amount of change during the waitlist period (for the WL group) 
versus during the intervention (for the IT group) for all primary outcome variables (GAD 
CSR, CGAS, CGI-S, CGI-I, and PSWQ). Additionally, paired-samples t-tests were used 
to assess within group differences regarding whether there was a significant change in 
children’s GAD diagnostic status and other primary and secondary outcome measures for 
the total sample following participation in the mindfulness intervention (WL and IT 
combined. Effect sizes were calculated in order to determine the impact of the 
intervention by comparing waitlist and immediate treatment groups. In addition, effect 
sizes were also calculated to compare change across the intervention phase in order to 
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provide an estimated impact of the intervention on outcome measures. While computing 
effect sizes for a pilot study with a small sample is unreliable (Kraemer, Mintz, Noda, 
Tinklenberg, & Yesavage, 2006), they still provide important data to guide future, larger 
studies. Considering the small sample size, our goal was to examine preliminary evidence 
of between group differences.  While we hoped to see large effect sizes in comparing the 
differences in mean change scores between the WL and IT groups, we did not anticipate a 
high degree of statistical significance, given that our study was not powered for it. 
Subclinical Diagnostic Status. Subclinical diagnostic status was defined as 
obtaining a GAD CSR ≤ 3 on the ADIS-IV-C/P. Over the waitlist period, 0% of the WL 
participants achieved subclinical diagnostic status. At post-treatment, 50% of participants 
in the WL achieved subclinical diagnostic status. For the IT only, immediately post-
treatment, 33% of the participants achieved subclinical diagnostic status for GAD. 
Collapsing the two groups, 42% of the participants achieved a subclinical GAD 
diagnostic status at post-treatment.  
 Clinical Severity of GAD Diagnosis. While both groups evidenced decrease in 
GAD CSRs, there was no significant difference in change scores of GAD CSRs at post-
waitlist/pre-treatment for the WL (M change = -.33, SD = .82) and at post-treatment for 
IT groups (M change = -1.17, SD = 1.17), t(10) = 1.43, p = .18 (two-tailed). The 
magnitude of the differences in the mean change scores (mean difference = .83, 95% CI: 
-.46 to 2.13) was large (d = .83) according to guidelines for evaluating effect sizes 
proposed by Cohen (1988). The change in GAD CSR for the IT group occurred in the 
expected direction; that is, CSRs improved following treatment participation. However, 
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GAD CSRs for the WL group also evidenced improvement. Table 11 shows the means 
and standard deviations of all change scores of outcome variables at pre- and post-
treatment assessments for the IT and WL. 
A paired-samples t-test was then conducted to evaluate the impact of the 
mindfulness intervention on participants’ clinical severity ratings of GAD across the total 
sample (WL and IT groups combined). Supporting our hypothesis, there was a 
statistically significant decrease in GAD CSR scores from pre-treatment (M = 5.17, SD = 
.72) to post-treatment (M = 3.75, SD = 1.29), t(11) = 4.93, p = .00. There was a very large 
effect size for this analysis (d = 1.42). However, there was not a statistically significant 
decrease in clinical severity ratings of GAD scores from post-treatment to 8-week follow-
up (M = 3.25, SD = 1.49), t(11) = 1.03, p = .32, d = .30 (small). When examining change 
from pre-treatment to follow-up, there was a significant decrease in GAD CSRs, t(11) = 
5.06, p = .00. There was a very large effect size for this analysis (d = 1.46).  
Functional Impairment. An independent-samples t-test was conducted to compare 
participants’ change scores on CGAS at post-waitlist/pre-treatment for the WL and at 
post-treatment for IT groups. While both groups evidenced change in CGAS in the 
expected direction, there was no significant difference in change scores of CGAS scores 
at post-waitlist/pre-treatment for the WL (M change = 1.33, SD = 3.14) and post-
treatment for the IT groups (M change = 5.00, SD = 10.04), t(10) = -.85, p = .41 (two-
tailed). The magnitude of the differences in the mean change scores (mean difference = -
3.67, 95% CI: -13.24 to 5.90) was moderate (d = .49). 
Across the total sample, supporting our hypothesis, there was a statistically 
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significant increase in CGAS scores from pre-treatment (M = 52.58, SD = 4.76) to post-
treatment (M = 61.33, SD = 10.34), t(11) = -3.40, p = .01. The effect size statistic (d = 
.98) indicated a large effect. However, while CGAS scores continued on an upward 
trajectory in the post-treatment period, there was not a statistically significant increase in 
CGAS scores from post-treatment to 8-week follow-up (M = 65.33, SD = 12.82), t(11) = -
1.24, p = .24, d = .36 (small). When examining change from pre-treatment to follow-up, 
there was a significant increase in CGAS scores, t(11) = -4.67, p = .001. There was a very 
large effect size for this analysis (d = 1.35).  
Global severity/improvement. Supporting our hypothesis, there was a significant 
difference in CGI-S change scores for the WL (M change = .17, SD = .41) and IT groups 
(M change = -.67, SD = .82), t(10) = 2.24, p = .049 (two-tailed). The magnitude of the 
differences in the mean change scores (mean difference = .83, 95% CI: .00 to 1.66) was 
very large (d = 1.30). It should be noted that the change in CGI-S scores for the IT group 
occurred in the expected direction of improvement while it appears CGI-S scores for the 
WL group got worse over the waitlist period.  
While we could not calculate change scores for CGI-I scores, given that the rating 
is not made at baseline, we examined what ratings were made at post-treatment for the IT 
group and at post-waitlist/pre-treatment for the WL group. As defined previously, 
treatment responders were those who scored < 2 on the CGI-I (‘2’ = much improved, ‘1’ 
= very much improved). On average, the improvement score for the WL group over the 
waitlist period indicated “no change” in clinical diagnosis relative baseline (or pre-
waitlist) while, on average for the IT group, the score indicated “minimally improved” 
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relative to baseline (or pre-treatment). More specifically, at post-waitlist for the WL 
group, four participants showed “no change” (CGI-I = 4) while two participants showed 
“minimal improvement” (CGI-I = 3). At post-treatment for the IT group, one participant 
was deemed a treatment responder (i.e., CGI-I < 2), while four showed “minimal 
improvement,” and one participant showed “no change” (CGI-I = 4).  
In examining the total sample, supporting our hypothesis, there was a statistically 
significant change in the anticipated direction for global severity as measured by the 
CGI-S from pre-treatment (M = 4.25, SD = .45) to post-treatment (M = 3.42, SD = .79), 
t(11) = 4.02, p = .002. There was a very large effect size for this analysis (d = 1.16). 
However, there was not a statistically significant change in CGI-S scores from post-
treatment to 8-week follow-up (M = 3.25, SD = 1.42, t(11) = .41, p = .67, d = .12 (small). 
When examining change from pre-treatment to follow-up, there was a significant 
decrease in CGI-S scores, t(11) = 2.25, p = .05, d = .65 (moderate).  
Again, given that CGI-I ratings are not made at baseline, we only examined 
change from post-treatment to follow-up. There was little change in CGI-I scores from 
post-treatment (M = 2.67, SD = .88) to 8-week follow-up (M = 2.67, SD = 1.30), t(11) = 
.00, p = .1.00, d = .00 (small). For the total sample, five out of the twelve (41.67%) 
participants were deemed treatment responders (i.e., CGI-I < 2). Four children were 
“much improved” (CGI-I = 2) and one was “very much improved” (CGI-I = 1). No 
participants got worse (CGI-I > 5), three participants showed “minimal improvement,” 
and two participants showed “no change” (CGI-I = 4).  
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Worry. While both groups evidenced decreases in PSWQ total T-scores, there was 
no significant difference in change scores on the PSWQ-C total T-scores for the WL (M 
change = -2.33, SD = 10.46) and IT groups (M change = -14.00, SD = 7.84), t(9) = 2.05, 
p = .07 (two-tailed). The magnitude of the differences in the mean change scores (mean 
difference = 11.67, 95% CI: -1.19 to 24.53) was very large (d = 1.26) and in the expected 
direction. 
 Supporting our expectations, we did find a statistically significant decrease in 
PSWQ T-scores across the total sample from pre-treatment (M = 57.56, SD = 15.90) to 
post-treatment (M = 45.00, SD = 13.43), t(8) = 4.86, p = .001. There was a very large 
effect size for this analysis (d = 1.62), which was in the expected direction. However, 
there was not a statistically significant decrease in PSWQ T-scores from post-treatment to 
8-week follow-up (M = 44.67, SD = 8.38), t(8) = .12, p = .91, d = .04 (small). When 
examining change from pre-treatment to follow-up, there was a significant decrease in 
PSWQ-C scores, t(11) = 2.65, p = .02, d = .76 (moderate). 
Assessment of Treatment Effects: Secondary Outcome Variables 
Parent-report of internalizing symptoms. Supporting our hypothesis, there was a 
significant difference in change scores on the CBCL Internalizing T-scores at post-
waitlist/pre-treatment for the WL (M change = -2.50, SD = 5.82) and IT groups (M 
change = -9.60, SD = 4.10), t(9) = 2.29, p = .048 (two-tailed). The magnitude of the 
differences in the mean change scores (mean difference = 7.10, 95% CI: .08 to 14.13) 
was very large (d = 1.41). In addition, there was also a significant difference in change 
scores on the CBCL Anxiety Problems subscale T-scores at post-waitlist/pre-treatment 
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for the WL (M change = -.67, SD = 3.01) and at post-treatment for the IT groups (M 
change = -8.60, SD = 6.12), t(9) = 2.82, p = .02 (two-tailed). The magnitude of the 
differences in the mean change scores (mean difference = 7.93, 95% CI: 1.57 to 14.30) 
was extremely large (d = 1.65).  
Regarding secondary measures of outcome for the total sample, supporting our 
hypothesis, there was a statistically significant decrease in CBCL Internalizing T-scores 
from pre-treatment (M = 68.90, SD = 8.29) to post-treatment (M = 62.20, SD = 6.05), t(9) 
= 4.21, p = .002, and CBCL Anxiety Problems T-scores from pre-treatment (M = 71.90, 
SD = 4.20) to post-treatment (M = 65.60, SD = 4.74), t(9) = 3.10, p = .013. The effect size 
statistics (d = 1.33 and .98, respectively) indicated large effect sizes for the total sample. 
However, there was not a statistically significant decrease in CBCL Internalizing T-
scores from post-treatment to 8-week follow-up (M = 59.30, SD = 6.60), t(9) = 1.58, p = 
.15, d = .50 (moderate), and CBCL Anxiety Problems T-scores from post-treatment to 8-
week follow-up, (M = 64.40, SD = 4.88), t(9) = 1.10, p = .30, d = .49 (moderate). When 
examining change from pre-treatment to follow-up, there was a significant decrease in 
both CBCL Internalizing scores, t(11) = 4.10, p = .002, and Anxiety Problems scores, 
t(11) = 4.34, p = .001. The effect size statistics (d = 1.18 and 1.25, respectively) indicated 
very large effect sizes.  
Child report of anxiety. There was not a significant difference in change scores on 
the MASC total T-scores for the WL (M change = -5.33, SD = 4.18) and IT groups (M 
change = -7.00, SD = 15.51), t(9) = .26, p = .81 (two-tailed). The magnitude of the 
differences in the mean change scores (mean difference = 1.67, 95% CI: -13.12 to 16.46) 
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was small (d = .15) and in the expected direction.  
Across the total sample, we did not observe a significant decrease in MASC total 
T-scores from pre-treatment (M = 43.33, SD = 10.69) to post-treatment (M = 38.56, SD = 
13.50), t(8) = 1.20, p = .26. There was a moderate effect for this analysis (d = .40) and 
this was in the expected direction. Similarly, there was not a statistically significant 
decrease in MASC T-scores from post-treatment to 8-week follow-up (M = 40.22, SD = 
11.79), t(8) = -.70, p = .51, d = .23 (small). This was not in the expected direction. When 
examining change from pre-treatment to follow-up, there was also no significant decrease 
in MASC scores, t(11) = .76, p = .46. There was a small effect size for this analysis (d = 
.23).  
Child report of mindfulness ability. There was not a significant difference in 
change scores on the CAMM total scores at for the WL (M change = 6.33, SD = 6.86) 
and IT groups (M change = -.83, SD = 5.46), t(10) = 2.00, p = .07 (two-tailed). The 
magnitude of the differences in the mean change scores (mean difference = 7.17, 95% CI: 
-.81 to 15.14) was very large (d = 1.16). It should be noted, however, that CAMM scores 
increased for the WL group over the waitlist period while scores slightly decreased for 
the IT group over the intervention period. 
For the total sample, there was not a significant increase in CAMM total scores 
from pre-treatment (M = 30.00, SD = 9.32) to post-treatment (M = 30.09, SD = 11.29), 
t(10) = -.07, p = .95. There was a very small effect size for this analysis (d = .02). 
Similarly, there was not a statistically significant increase in CAMM total scores from 
post-treatment to 8-week follow-up (M = 31.36, SD = 11.09), t(10) = -.61, p = .56, d = 
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.18 (small). When examining change from pre-treatment to follow-up, there was also not 
a significant decrease in CAMM scores, t(11) = -.61, p = .55, d = .18 (small). 
Child report of metacognition. There was not a significant difference in change 
scores on the MCQ-C total scores for the WL (M change = -6.83, SD = 4.40) and IT 
groups (M change = -6.67, SD = 6.02), t(10) = -.06, p = .96 (two-tailed). The magnitude 
of the differences in the mean change scores (mean difference = -.17, 95% CI: -6.95 to 
6.62) was small (d = .03). Additionally, when examining each subscale independently, 
there were no significant differences in change scores on any of the four subscales. 
Specifically, there was no significant difference in the Positive Meta-Worry subscale for 
the WL (M change = -.33, SD = 1.03) and IT groups (M change = .67, SD = .82), t(10) = 
-1.86 p = .09 (two-tailed). The magnitude of the differences in the mean change scores 
(mean difference = -1.00, 95% CI: -2.20 to .20) was very large (d = 1.07). Similarly, 
there was no significant difference in change scores on the Negative Meta-Worry 
subscale for the WL (M change = -3.33, SD = 1.75) and IT groups (M change = -1.83, SD 
= 2.56), t(10) = -1.18, p = .26 (two-tailed). The magnitude of the differences in the mean 
change scores (mean difference = -1.50, 95% CI: -4.32 to 1.32) was moderate (d = .68). 
There was no significant difference in the SPR subscale for the WL (M change = -1.17, 
SD = 1.47) and IT groups (M change = -.83, SD = 2.56), t(10) = -.28 p = .0 (two-tailed). 
The magnitude of the differences in the mean change scores (mean difference = -.33, 
95% CI: -3.02 to 2.35) was small (d = .16). When only examining change scores on the 
Cognitive Monitoring subscale, there was also no significant difference in change scores 
in this subscale for the WL (M change = -2.00, SD = 2.90) and IT groups (M change = -
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4.67, SD = 3.88), t(10) = 1.35, p = .21 (two-tailed). The magnitude of the differences in 
the mean change scores (mean difference = 2.67, 95% CI: -1.74 to 7.07) was large (d = 
.78).  
Finally, there was a trend towards significance for an increase in the total sample 
in MCQ total scores from pre-treatment (M = 42.45, SD = 14.66) to post-treatment (M = 
38.64, SD = 14.02), t(10) = 2.18, p = .054.There was a moderate effect size for this 
analysis (d = .66). However, there was not a statistically significant increase in MCQ 
total scores from post-treatment to 8-week follow-up (M = 34.36, SD = 13.63), t(10) = 
2.00, p = .07, d = .60 (moderate).  
Next, each subscale of the MCQ-C was examined. There was no significant 
change in Positive Beliefs about Worry subscale from pre-treatment (M = 6.73, SD = 
1.62) to post-treatment (M = 6.91, SD = 2.12), t(10) = -.69, p =.51, d = .21 (small). This 
was also true from post-treatment to follow-up, (M = 6.73, SD = 1.27), t(10) = .25, p 
=.81, d = .08 (small).   
Nor did we find any significant change in Negative Beliefs about Worry subscale 
from pre-treatment (M = 12.91, SD = 5.89) to post-treatment (M = 11.64, SD = 5.20), 
t(10) = 1.64, p = .13, d = .50 (moderate). However, there was a significant difference in 
this subscale from post-treatment to follow-up, (M = 9.82, SD = 4.94), t(10) = 2.47, p 
=.03, d = .74 (large), in the expected direction, such that children reported a decrease in 
negative beliefs about worry 8 weeks after receiving the intervention.  
When parsing out the Cognitive Monitoring subscale of the MCQ-C for the total 
sample, while there was not significant change in awareness and reporting of thoughts 
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from pre-treatment (M = 12.91, SD = 5.80) to post-treatment (M = 10.82, SD = 4.69), 
t(10) = 1.66, p =.13, d = .50 (moderate), there was a significant decrease in scores from 
post-treatment to follow-up (M = 9.09, SD = 4.44), t(10) = 2.51, p = .03, d = .76 
(moderate). However, this direction of change was contrary to expectations.  
Finally, we did not find any significant change in scores on the SPR subscale 
from pre-treatment (M = 9.91, SD = 4.01) to post-treatment (M = 9.27, SD = 4.25), t(10) 
= 1.08, p =.31, d = .32 (small). This was also true from post-treatment to follow-up, (M = 
8.73, SD = 4.45), t(10) = 1.00, p =.34, d = .30 (small). 
When examining change from pre-treatment to follow-up in the total sample (N = 
12), there was a significant decrease in MCQ-C total scores, t(11) = 2.30, p = .04, d = .66 
(moderate), in the Cognitive Monitoring subscale, t(11) = 2.26, p = .05 d = .65 
(moderate), and the Negative Beliefs about Worry subscale, t(11) = 2.35 p = .04, d = .68 
(moderate). However, we did not find significant change in the Positive Beliefs about 
Worry subscale, t(11) = .00, p = 1.00, d = .00 (small), nor for the SPR subscale, t(11) = 
1.51, p = .16, d = .43 (small). 
Maintenance of Treatment Gains 
Examining the total sample (combined waitlist and immediate treatment for a 
total of 12 participants), 58% of the participants had achieved subclinical diagnostic 
status at the follow-up assessment.  
To examine the impact of the intervention on anxiety comorbidity, as assessed by 
the ADIS-IV-C/P, changes in number of comorbid anxiety diagnoses were also 
examined. As seen in Table 12, three participants who had a comorbid anxiety diagnosis 
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at pre-treatment showed improvement over time in that their comorbid diagnosis no 
longer met clinical severity criteria at post-treatment. We were unable to perform 
statistical analyses, however, due to the small number of subjects with comorbid 
diagnoses.  
Associations between Anxiety Symptoms, Mindfulness Ability, and Metacognition 
Lastly, we were interested in examining the relationship between anxiety 
symptoms, mindfulness ability, and metacognitive ability. Specifically, we were 
predicting that higher levels of mindfulness ability, as measured by the CAMM, would be 
significantly correlated with lower levels of worry, as measured by the PSWQ-C, at post-
treatment. However, there were no significant associations found at either pre-treatment, 
r = -.52, n = 12, p = .08, or post-treatment, r = -.18, n = 9, p = .65 between mindfulness 
ability and worry. However, there was a significant association found at follow-up, r = -
.64, n = 12, p = .026. 
Additionally, we hypothesized that higher levels of metacognition, as measured 
by the Cognitive Monitoring subscale of the MCQ-C, would be significantly correlated 
with higher levels of mindfulness ability, as measured by the CAMM, at post-treatment. 
While was a significant relationship between cognitive monitoring (i.e., awareness and 
reporting of thoughts) and mindfulness ability, r = -.84, n = 11, p = .001, it was not in the 
expected direction. That is, higher levels of mindfulness ability were associated with 
lower levels of cognitive monitoring. To further understand this relationship, we 
examined associations at both pre-treatment, r = -.78, n = 12, p = .003, and at follow-up, 
r = -.89, n = 12, p = .000, and found a similar relationships. 
  
53 
53 
Lastly, we were interested in exploring the relationship between worry and 
metacognition at post-treatment. We found that worry, as measured by the PSWQ, was 
not associated with more awareness of thoughts, as measured by the Cognitive 
Monitoring subscale of the MCQ-C, at post-treatment, r = .15, n = 9, p = .71. 
Treatment Satisfaction 
 Both parents (M = 4.13, SD = .74) and children (M = 3.40, SD = 1.42) reported a 
high level of treatment satisfaction measure. Additionally, across the 11 items, both 
parents and children reported a very high level of treatment satisfaction on the 1-5 scale 
provided (M = 3.92, SD = .95). Moreover, qualitative responses provided further support 
for the mindfulness intervention. Comments included, “It is a wonderful, practical 
experience for both parent and child. You both walk away with valuable information and 
tools. There is hope.” One parent noted, “The therapist presented skills that helped my 
child. [My child] was eager to try the exercises at home and school and felt very 
comfortable talking about them.” Another parent reported, “I would definitely not 
hesitate to recommend this treatment to a friend. I would say that the exercises that they 
learn gave them some really good tools for dealing with anxiety.” 
Discussion 
The results of this study provide preliminary support for the feasibility, 
acceptability, safety, and potential efficacy of a brief 6-week mindfulness intervention for 
children with GAD. First, the intervention was feasible. Families of children on the clinic 
waitlist were interested in participating in a mindfulness-based assessment, and 
recruitment was relatively easy.  Families who enrolled tended to complete the treatment. 
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Specifically, out of a total of sixteen participants, we experienced only one premature 
termination, which occurred after three treatment sessions due to maternal health issues. 
However, this family continued to participate in the post-treatment and follow-up 
assessments. Otherwise, all other participants in the WL and IT groups, and the four 
participants the pilot phase, completed all treatment sessions.  
Second, families reported high acceptability and satisfaction with the intervention. 
In addition, qualitative responses from parents and children indicated that the treatment 
made sense to families, that they learned useful skills to manage anxiety, and saw 
positive effects.  
Third, the intervention was safe. There were no adverse events that occurred 
during the intervention and no child’s symptoms worsened during the course of the 
intervention. Interestingly, during the follow-up period, 3 children evidenced some loss 
of treatment gains, suggesting the possible need for longer term follow-up. 
Fourth, the intervention evidenced preliminary efficacy. Relative to waitlist, 
children in the treatment group showed statistically significant improvements in change 
scores on CGI-S scores and CBCL Internalizing and Anxiety Problems T-scores. 
Although the direction of effects is as expected, the statistical significance was 
unexpected given the sample was not sized to have adequate power for the statistical 
analyses used. It appears that while the total group improved on both primary and 
secondary outcome measures, there were no statistically significant between group 
effects to account for the influence of treatment condition. Again, this result is not 
surprising given that our sample was not adequately powered; however, results do 
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indicate large between group effect sizes, suggesting the need for a larger RCT study to 
adequately assess statistical between group differences.  
In addition to reductions in GAD diagnostic severity, we hypothesized that 
children in the immediate treatment group would display greater improvements in change 
scores for other primary outcomes measures (i.e., functional impairment and PSWQ-C 
scores) from pre-treatment to post-treatment when compared to the waitlist group. Again, 
while we did not anticipate finding statistical significance, the results suggest a moderate 
group difference for functional impairment, as measured by the CGAS, and a large group 
difference for child-report of worry, as measured by the PSWQ-C. While the immediate 
treatment group was not superior on change scores for MASC total scores at the post-
treatment assessment point when compared to post-waitlist/pre-treatment assessment 
point for the waitlist group, our results indicated a small between groups difference. 
Supporting our hypothesis, as mentioned above, the immediate treatment group did 
evidence greater improvements on change scores for CBCL Internalizing and Anxiety 
Problems T-scores at post-treatment when compared to the waitlist group at post-
waitlist/pre-treatment, both of which evidenced large between group differences.  
Overall, the current study evidenced very large effect size estimates, which is 
quite remarkable for a pilot study of such a small sample size. In a meta-analysis of adult 
mindfulness studies, Baer (2003) found a mean effect size of d = .59 (SD = .41). By 
comparison, Lee and colleagues (2008) found a small to medium effect size for their 
open trial of Mindfulness-based Cognitive Therapy (MBCT-C) for children ages 9 to 12, 
while Biegel and colleagues (2009) reported a range of d = .59 to 1.02, indicating 
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moderate to large effect sizes, for their trial of Mindfulness-based Stress Reduction 
(MBSR) for adolescents. The current study found similar effect sizes, despite mostly non-
significant findings, suggesting the need for a future, larger randomized clinical trial to 
fully evaluate treatment efficacy. 
While we cannot attribute treatment outcomes entirely to the intervention, when 
examining changes in pre-treatment differences to post-treatment differences for the total 
sample, we did find changes in outcomes. Specifically, when examining the total group 
(n  = 12) together, at the post-treatment assessment, 42% of participants (n = 5) entered 
into the subclinical range on GAD clinical severity. Indeed, by the 8-week follow-up, 
58% of participants (n = 7) had entered into the subclinical range on GAD clinical 
severity. In other initial clinical trials of CBT for child anxiety, studies showed 
percentages of children diagnosis-free at post-treatment ranging from 57% (Barrett, 
Dadds, & Rapee, 1996) to 64% (Kendall, 1994). In a randomized clinical trial of MBSR 
for adolescents with a range of diagnoses, including mood and anxiety disorders, more 
than 45% of the sample showed diagnostic improvement by post-treatment (Biegel, 
Brown, Shapiro, & Schubert, 2009). Our findings seem comparable to not only studies 
evaluating mindfulness-based treatments for children and adolescents, but also trials of 
CBT for child anxiety. 
Regarding additional outcome measures, on average, children’s global assessment 
scale (CGAS) ratings improved by one domain range. Additionally, there was also a 
significant decrease in clinical global severity (CGI-S) from pre-treatment to post-
treatment. However, this was not true for clinical global improvement (CGI-I), which 
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takes into account pre-treatment diagnostic severity. When examining the data more 
closely, children at pre-treatment had CGI-S scores of “markedly ill” or “moderately ill”. 
By post-treatment, while two participants had “no change” in clinical global 
improvement (CGI-I), all other participants (n = 14) were rated CGI-I scores of 
“minimally improved,” “much improved,” or “very much improved.”  We also 
anticipated that children would display improvements in secondary outcome measures of 
anxiety and worry following the intervention. Our results partially support this 
hypothesis. Specifically, we found significant reductions in PSWQ T-scores and CBCL 
Internalizing and Anxiety Problems T-scores, but not with MASC total T-scores. 
Previous research has indicated that the PSWQ-C reliably discriminates GAD from other 
anxiety disorders (Muris, Meesters, & Gobel, 2001; Pestle, Chorpita, & Schiffman, 
2008), so it may be that the PSWQ-C is a more sensitive measure and, therefore, a better 
indication of change in worry than the MASC, particularly for the current study, in which 
all children had a primary GAD diagnosis prior to treatment.  
In addition, we hypothesized that all children receiving the intervention would 
evidence increases in both mindfulness ability, as measured by the CAMM, and increases 
in metacognition, as measured by the MCQ-C. Results indicated that there was not a 
significant increase in mindfulness ability after receiving the intervention when 
examining the total sample. On the other hand, there was evidence of a significant trend 
in increases in metacognitive abilities after receiving the intervention when examining 
the total scale on the MCQ, which include scales measuring both positive and negative 
beliefs about worry; superstitious, punishment and responsibility (SPR) beliefs about 
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worry; and cognitive monitoring (or awareness of one’s thoughts). However, examining 
the total score of the MCQ-C is not very informative given that the instrument is made up 
of four different subscales measuring various meta-cognitive beliefs about worry. 
Therefore, we chose to examine each subscale separately and how children’s 
metacognitive beliefs about worry may change after the mindfulness intervention. While 
there were no significant changes from pre-treatment to post-treatment for any of the 
MCQ-C subscales, we did find that, from post-treatment to follow-up, there was a 
significant decrease in children’s negative beliefs about worry. This would be expected, 
given that previous research has found that holding negative meta-worry is what 
distinguishes individuals with GAD from other anxiety disorders (Wells & Carter, 1999). 
Therefore, the decrease in negative meta-worry may be an indication that children are 
continuing to improve and are reporting fewer GAD worries, especially in light of the 
fact that 5 out of the 12 children (58%) entered into a subclinical range on GAD clinical 
severity by the follow-up assessment time point. 
Of note, although this was not a specific study hypothesis, we found a 
significantly high correlation between PSWQ scores and MCQ-C Negative Beliefs about 
Worry subscale scores at both pre-treatment and post-treatment (r = .80, p = .002 and r = 
.92, p = .001, respectively). This is consistent with previous research (Smith & Hudson, 
2013; Muris et al., 1998; Perrin & Last, 1997) that found children with anxiety, 
specifically GAD, scored higher in this subscale. Wells and Carter (1999), along with 
other researchers, have posited that these negative beliefs about worry are unique to 
individuals with GAD. In other words, holding negative beliefs about worry, such as the 
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danger and uncontrollability about worry, may be what distinguishes children with GAD 
from other anxiety disorders. This correlation is just as strong at the follow-up assessment 
time point (r = .83, p = .001) even though by the post-treatment, 58% of the participants  
(n = 7) had entered into a subclinical diagnosis of GAD. In examining the original 
development of MCQ-C measure, Bacow and colleagues (2009) found that children with 
anxiety (compared to non-clinical children), scored lower on all MCQ-C scales, 
reasoning that children with anxiety disorders may wish to avoid their worries/thoughts 
as a coping strategy (i.e., cognitive avoidance). In this light, the negative correlation 
between mindfulness ability and cognitive monitoring that we found in the current study 
may not be so surprising. Although mindfulness provides a specific set of skills for 
children (and adults) to learn how to be present in the current moment, thus allowing for 
an exposure of sorts for paying attention to anxiety and worries, it could be that there are 
other potential mechanisms in the way mindfulness may impact anxiety.  
When parsing out the Cognitive Monitoring subscale, contrary to expectations, 
there were no significant increases in this area of metacognitive abilities after receiving 
the intervention. This result was surprising, given that we would have expected that 
Cognitive Monitoring would increase as a result of a mindfulness intervention. In other 
words, we would have expected children would report more awareness of thoughts 
following a mindfulness intervention because one aspect of mindfulness is learning to 
pay attention to one’s thoughts without judgment and with acceptance. However, this was 
not the case. It may be that the Cognitive Monitoring scale, and the MCQ-C measure in 
general, does not capture all of the complexities of mindfulness, given that mindfulness 
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encompasses not just awareness of the present moment through one’s cognitions but also 
awareness of emotions and body sensations of an individual using all five senses. In 
addition, the MCQ-C was designed to capture metacognitive beliefs about worry and not 
the development of normative metacognitive abilities. Consequently, as mentioned 
above, more than half the child no longer met diagnostic criteria for GAD at post-
treatment, therefore, they may not have held metacognitive beliefs about worry any 
longer but the MCQ-C was not able to capture that. Therefore, these results must be 
interpreted with caution given that there has not been extensive research using the 
CAMM and MCQ-C measures nor comprehensive validity or reliability data on these 
measures.  
Limitations and Future Directions 
 The current study is the first randomized-controlled trial using a mindfulness 
intervention specifically targeted for children with GAD and provides initial evidence to 
support the treatment’s feasibility, safety, acceptability, and potential efficacy on GAD 
diagnostic severity. However, there are several limitations to this study that offer future 
directions for research.  
 As expected for a small study sample, we did not find significant improvements 
among the treatment group, relative to waitlist, on primary and secondary outcome 
measures, except on CGI-S and CBCL Internalizing and Anxiety Problems scales. One 
reason may be the limited power due to the small sample size. Future research should 
include a large enough sample size that would have enough power to conduct analyses in 
order to examine main effects of treatment condition. Indeed, our promising effect size 
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estimates indicate that a large randomized control trial is warranted to fully examine 
treatment efficacy. 
 Another limitation may be the brief nature, or “dose,” of the intervention. Six 
sessions is a fairly brief and limited intervention targeting the reduction of anxiety 
symptoms, yet the current study found that 50% of participants at post-treatment and 69% 
of participants at the follow-up assessment showed GAD recovery. Future studies may 
want to investigate both smaller and larger doses to more fully examine how that may 
impact the maintenance of treatment gains over time. 
Another aim of our study was to examine associations between mindfulness 
ability, anxiety symptoms, and metacognitive abilities. Many strategies have been used to 
assess metacognitive processes in children from an executive functioning standpoint, but 
fairly limited research has been done examining how metacognition is impacted by 
mindfulness treatments in anxious children. It is clear much more research is needed to 
examine the potential associations between metacognitive abilities, anxiety symptoms, 
and mindfulness ability. Thus, it may not be surprising that we found mixed results in our 
study for these constructs given the limited availability of developmentally sensitive and 
sound measurements in this area, which is certainly an area of need for future research. In 
addition, it may be that measurements need to be developed that more sensitively capture 
all aspects of mindfulness, such as nonjudgmental attitude and awareness of the present 
moment. It may be that in developing mindfulness measures, there may be a need to 
encompass several subscales to parse out the different aspects of mindfulness. Regarding 
the current study, it is unclear from the measurements we have whether children have not 
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yet developed the capacity to have certain metacognitive beliefs or whether children 
possess metacognitive capacities but no longer hold metacognitive beliefs regarding 
worry. In addition, it is unclear whether current instruments (such as the MCQ-C) are not 
yet able to measure the construct of metacognition fully, speaking again for the clear 
need of understanding current instruments more fully and the need for more 
developmentally sensitive measures. Regardless of the mixed findings, the current study 
provides evidence supporting the role of potential importance that metacognitive beliefs 
may play in clinical anxiety disorders in children. Future research in this area should 
continue examining the relationship between mindfulness and child anxiety, especially 
the potential mediating and/or moderating role metacognition may play in the 
relationship between mindfulness abilities and symptoms of GAD in children. 
Despite possible limitations, given the intervention’s evidenced feasibility, high 
acceptability and satisfaction among parents and children, demonstrated safety, and 
preliminary efficacy, these findings suggest one delivery method of mindfulness 
treatment that is brief and focused, especially given limitations in the dissemination of 
standard child anxiety treatment. Compared to a more standard course of CBT that may 
last up to five months, this type of brief treatment may provide an alternative method of 
delivery and may be a possibility to implement in various treatment settings, such as 
community clinics. Overall, the current study provides promising initial evidence of 
reducing anxiety symptoms in children using a mindfulness intervention and 
demonstrates support of conducting a larger randomized clinical trial for pediatric anxiety 
disorders.
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Figure 1. Flow of participants through pre- and post-assessment in the waitlist- 
controlled trial 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Randomized 
n = 12 
 
Eligible  
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of study  
n = 4 
Excluded n = 12 
 Ineligible n = 4 
 Lost contact n = 3 
 Not interested n = 5 
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n = 31 
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ineligibility  
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diagnostic assessment  
n = 19 
 
Completed post-treatment 
assessment n = 6 
       
Completed 8-week follow-up 
assessment n = 6 
Assigned to waitlist  
     n = 6 
Completed post-waitlist    
     assessment n = 6 
Completed treatment n = 6 
 
6 subjects included in analyses 
Completed post-treatment 
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     Withdrew due to maternal     
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Table 1. Mindfulness Treatment Studies for Children 
Reference Subjects Diagnostic 
Assessment 
Format(s) Mindfulness 
Intervention 
Diagnostic 
Target 
Post-Intervention 
Assessment 
Beigel et al., 
2009 
Ages 14-18  
(n=102) 
DSM-IV 
criteria; PSS-
10; SCL-90-R 
Group MBSR Anxiety and 
Mood 
Disorders 
Immediate; 3 months 
Liehr & Diaz, 
2010 
Ages 7-12 
(n=18) 
SMFQ; SAIC Group Mindful awareness 
to breath, 
movement, & 
generosity 
Anxiety and 
Depressive 
Symptoms 
Immediate 
Lee et al., 2008 Ages 9-12 
(n=25) 
CBCL; MASC, 
STAIC; RCDS 
Group MBCT-C Academic 
Problems 
Immediate 
Semple et al., 
2005 
Ages 7-8 
(n=5) 
CBCL; MASC; 
STAIC 
Group MBCT-C Anxiety 
Symptoms 
Immediate 
Semple et al., 
2010 
Ages 9-13 
(n=25) 
CBCL; MASC; 
STAIC 
Group MBCT-C Academic 
Problems 
Immediate; 3 months 
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Table 2. Overview of the AWARE Program 
Session 
1 
Psychoeducation with both parent and child; Defining mindfulness; 
Emphasizing the importance of practicing and homework; Explaining 
judging versus noticing thoughts and feelings; Introducing Mindful Eating; 
Child teaches parent skill learned. 
Review of mindfulness practice done over past week; Problem-solving 
barriers to practicing mindfulness; Introducing Mindful Touching; Child 
teaches parent skill learned. 
Review of mindfulness practice over past week; Introducing Mindful 
Movement; Child teaches parent skill learned. 
Review of mindfulness practice over past week; Introducing Mindful 
Listening (practicing both indoors and outdoors); Child teaches parent skill 
learned. 
Sessions 
2-5 
 
Review of mindfulness practice over past week; Introducing Mindful 
Breathing; Child teaches parent skill learned. 
Session 
6 
Review of mindfulness skills learned; Examining child’s overall experience 
with mindfulness; Discussing how to use mindfulness in everyday life; 
Taking stock of what the child accomplished. 
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Table 3. Demographic Information, Diagnostic Status, and Clinical Severity at Pre-
Treatment, Post-Treatment, and 8-week Follow-Up 
Participant Demographic Info   Diagnostic Status (CSR; 0-8 scale) 
 Age Ethnicity Gender  Pre Post 8-wk F/U 
1 11 Caucasian Female  GAD (6) GAD (5) GAD (2) 
     SOC (4) SOC (4) SOC (3) 
2 9 Caucasian Male  GAD (6) GAD (3) GAD (2) 
     SOC (4) SOC (6) SOC (6) 
3 10 Caucasian Female  GAD (4) GAD (3) GAD (3) 
4 10 Caucasian Male  GAD (4) GAD (2) GAD (1) 
     SOC (4) SOC (2) SOC (1) 
     Spec (4) Spec (2) Spec (2) 
 
Notes. CSR = Clinical Severity Rating, a score of 4 or above is considered to be a 
clinical diagnosis; GAD = Generalized Anxiety Disorder; SOC = Social Phobia; Spec = 
Specific Phobia. 
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Table 4. Functional Impairment and Clinical Global Severity and Improvement Scores at 
Pre-Treatment, Post-Treatment, and 8-week Follow-Up 
Participant CGAS  CGI-S (0-7 scale)  CGI-I (0-7 scale) 
 Pre Post F/U  Pre Post F/U  Pre Post F/U 
1 55 65 76  4 3 2  0 3 2 
2 48 45 45  5 5 5  0 3 3 
3 55 61 70  4 3 2  0 3 2 
4 48 85 88  5 1 1  0 1 1 
 
Notes. CGAS = Children’s Global Assessment Scale; CGI-S = Clinical Global 
Impression-Severity Scale; CGI-I = Clinical Global Impression-Improvement Scale; Pre 
= pre-treatment; Post = post-treatment, F/U = follow-up 
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Table 5. CBCL Internalizing and Anxiety Problems, PSWQ-C, and MASC T-scores at pre-treatment, post-treatment, and 8-
week follow-up 
Participant CBCL Int. Prob.  CBCL Anx. Prob.  PSWQ-C  MASC 
 Pre Post F/U  Pre Post F/U  Pre Post F/U  Pre Post F/U 
1 72 52 52  73 59 51  62 41 43  36 41 37 
2 72 70 65  73 70 68  57 52 48  56 57 59 
3 75 67 67  72 70 67  44 40 34  41 41 33 
4 70 48 48  72 55 51  46 32 35  50 42 46 
 
Notes. CBCL Int, Anx = Child Behavior Checklist Internalizing and Anxiety Problem Scale; PSWQ-C = Penn State Worry 
Questionnaire for Children; MASC = Multidimensional Anxiety Scale for Children, Total scale; Pre = pre-treatment; Post = 
post-treatment, F/U = follow-up
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Table 6. CAMM and MCQ-C Total Scores at pre-treatment, post-treatment, and 8-week 
follow-up 
Participant CAMM  MCQ-C Total 
 Pre Post F/U  Pre Post F/U 
1 38 37 36  44 40 31 
2 29 24 26  36 41 40 
3 18 27 32  34 45 45 
4 21 22 20  40 34 37 
 
Notes. CAMM = Child and Adolescent Mindfulness Measure; MCQ-C Total = 
Metacognitions Questionnaire for Children, Total scales; Pre = pre-treatment; Post = 
post-treatment, F/U = follow-up 
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Table 7. MCQ-C Positive Meta-Worry, Negative Meta-Worry, SPR, and Cognitive Monitoring Subscale Scores   
Participant Positive  Negative  SPR Beliefs  Cognitive 
 Pre Post F/U  Pre Post F/U  Pre Post F/U  Pre Post F/U 
1 6 6 6  12 12 9  10 9 7  16 13 9 
2 7 7 6  11 9 12  7 13 12  11 12 10 
3 6 9 15  11 9 6  9 9 8  8 18 16 
4 7 6 6  10 8 8  10 9 9  13 11 14 
 
Notes. Positive = Positive Beliefs about Worry subscale; Negative = Negative Beliefs about Worry subscale; SPR = 
Superstition, Punishment, and Responsibility Beliefs subscale; Cognitive = Cognitive Monitoring subscale; Pre = pre-
treatment; Post = post-treatment, F/U = follow-up 
        
 
 
71 
71 
Table 8. Sample Characteristics 
 Open Trial 
(n = 4) 
Treatment 
(n = 6) 
Waitlist 
(n = 6) 
Comparing 
Immediate to 
Waitlist  
 mean (SD) mean (SD) mean (SD) t p 
Age 10.00 (0.86) 10.50 (1.38) 10.67 (1.03) 0.24 0.82 
Race 100% 
Caucasian 
100% 
Caucasian 
66.67% Caucasian - - 
 - - 16.67% African 
American 
- - 
 - - 16.67% Biracial - - 
Current 
medication 
0% 40% 16.67% - - 
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Table 9. Means and Standard Deviations of Outcome Measures at Pre-treatment, Post-waitlist, Post-treatment, and Follow-up 
Assessments by Treatment Condition for Study 2 
 
 
Open Trial (n = 4) Immediate (n = 6) Waitlist (n = 6) 
 mean (SD) mean (SD) mean (SD) 
 Pre-tx Post-tx F/U Pre-tx Post-tx F/U Pre-WL Post-WL / 
Pre-tx 
Post-tx F/U 
GAD CSR 5.50 
(1.00) 
3.25 
(1.26) 
2.00 
(0.82) 
5.33 
(.52) 
4.17 
(1.60) 
4.17 
(1.33) 
5.33 (.82) 5.00  (.89) 3.33  
(.82) 
2.33 
(1.03) 
CGAS 51.50 
(4.04) 
64.00 
(16.45) 
69.75 
(18.12) 
51.33 
(4.32) 
56.33 
(10.67) 
57.67 
(7.29) 
52.50 
(4.18) 
53.83 
(5.23) 
66.33 
(7.84) 
73.00 
(12.95) 
CGI-S 4.50 
(0.58) 
3.00 
(1.63) 
2.50 
(1.83) 
4.17 
(.41) 
3.50 
(.84) 
4.17 
(1.17) 
4.17 (.41) 4.33  (.52) 3.33  
(.82) 
2.33 
(1.03) 
CGI-I - 2.50 
(1.00) 
2.00 
(0.82) 
- 3.00 
(.63) 
3.33 
(1.21) 
- 3.67  (.52) 2.33 
(1.03) 
2.00 
(1.10) 
CBCL Int 72.25 
(2.01) 
59.25 
(10.87) 
58.00 
(9.42) 
73.00 
(3.69) 
63.80a 
(4.09) 
62.67 
(6.35) 
67.00 
(6.16) 
64.50 
(8.41) 
60.60a 
(7.70) 
57.67 
(7.01) 
CBCL Anx 72.50 63.50 59.25 73.83 64.60a 66.83 71.67 71.00 66.60a 64.33 
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(0.58) (7.68) (9.54) (1.84) (5.60) (7.47) (3.72) (5.33) (4.10) (3.50) 
MASC Tot 45.75 
(8.96) 
45.25 
(7.85) 
43.75 
(11.53) 
56.67 
(17.66) 
43.00a 
(16.02) 
50.17 
(21.96) 
39.17 
(5.57) 
33.83 
(6.85) 
33.00b 
(8.37) 
36.00 
(11.92) 
PSWQ-C 52.25 
(8.66) 
41.25 
(8.22) 
40.00 
(6.68) 
67.50 
(14.92) 
52.00a 
(14.87) 
53.83 
(11.58) 
45.67 
(10.95) 
43.33 
(8.57) 
36.25b 
(1.50) 
39.33 
(4.93) 
CAMM 26.50 
(8.06) 
27.50 
(6.66) 
28.50 
(7.00) 
26.67 
(10.31) 
25.83 
(13.76) 
28.67 
(13.77) 
28.50 
(5.09) 
34.83 
(6.49) 
35.20a 
(4.71) 
34.83 
(6.15) 
MCQ-C Tot 38.50 
(4.44) 
40.00 
(4.55) 
38.25 
(5.82) 
50.83 
(15.03) 
44.17 
(17.44) 
37.87 
(17.95) 
38.17 
(6.68) 
31.11 
(5.05) 
32.00a 
(3.16) 
30.83 
(4.45) 
MCQ-C Pos 6.50 
(0.58) 
7.00 
(1.41) 
8.25 
(4.50) 
6.67 
(2.16) 
7.33 
(2.81) 
6.33 
(.52) 
7.00 
(1.55) 
6.67  (.82) 6.40a  
(.89) 
7.00 
(1.67) 
MCQ-C Neg 11.00 
(0.82) 
9.50 
(1.73) 
8.75 
(2.50) 
16.33 
(5.82) 
14.50 
(5.61) 
11.50 
(6.35) 
11.67 
(1.75) 
8.33 
(2.42) 
8.20a 
(1.10) 
7.83 (.98) 
MCQ-C Super 9.00 
(1.41) 
10.00 
(2.00) 
9.00 
(2.16) 
11.33 
(4.97) 
10.50 
(5.43) 
9.67 
(5.68) 
9.33 
(1.51) 
8.17 
(1.47) 
7.80a 
(1.79) 
8.00 
(2.45) 
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MCQ-C Cog 12.00 
(3.37) 
3.50 
(3.11) 
12.25 
(3.30) 
16.50 
(5.68) 
11.84 
(6.24) 
10.33 
(5.79) 
10.17 
(3.19) 
8.17 
(1.47) 
9.60a 
(1.67) 
8.00 
(1.67) 
 
Notes. a = n of 5; b = n of 4; GAD CSR = clinical severity rating of GAD; CGAS = Children’s Global Assessment Scale; CGI-
S = Clinical Global Impression-Severity Scale; CGI-I = Clinical Global Impression-Improvement Scale; CBCL Int, Anx = 
Child Behavior Checklist, Internalizing and Anxiety Problem Scale; MASC Tot = Multidimensional Anxiety Scale for 
Children, Total Scale; PSWQ-C = Penn State Worry Questionnaire for Children; CAMM = Child and Adolescent Mindfulness 
Measure; MCQ-C Tot, Pos, Neg, Super, Cog = Metacognitions Questionnaire for Children, Total, Positive Meta-worry, 
Negative Meta-worry, Superstitious, and Cognitive Monitoring scales
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Table 10. Means and Standard Deviations of Outcome Measures in Combined Sample for 
Study 2 (N = 12) 
 Pre-Treatment  Post-Treatment Follow-up 
GAD CSR 5.17 (.72) 3.75 (1.29) 3.25 (1.49) 
CGAS 52.58 (4.76) 61.33 (10.34) 65.33 (12.82) 
CGI-S 4.25 (.45) 3.42 (.79) 3.25 (1.42) 
CGI-I - 2.67 (.89) 2.67 (1.30) 
CBCL Internalizing 68.75 (7.62) 62.20 (6.05) 60.17 (6.89) 
CBCL Anxiety 72.42 (4.08) 65.60 (4.74) 65.58 (5.71) 
MASC Total 45.25 (17.43) 38.56 (13.50) 43.08 (18.40) 
PSWQ-C 55.42 (17.14) 45.00 (13.43) 46.58 (11.37) 
CAMM 30.75 (9.26) 30.09 (11.29) 31.75 (10.66) 
MCQ-C Tot 41.08 (15.76) 38.64 (14.02) 34.33 (12.99) 
MCQ-C Pos 6.67 (1.56) 6.91 (2.12) 6.67 (1.23) 
MCQ-C Neg 12.33 (5.96) 11.64 (5.20) 9.67 (4.74) 
MCQ-C Super 9.75 (3.86) 9.27 (4.25) 8.83 (4.26) 
MCQ-C Cog 12.33 (5.88) 10.82 (4.69) 9.17 (4.24) 
Notes. Pre-treatment data includes pre-treatment for immediate treatment group and post-
waitlist data for waitlist group; GAD CSR = clinical severity rating of GAD; CGAS = 
Children’s Global Assessment Scale; CGI-S = Clinical Global Impression-Severity Scale; 
CGI-I = Clinical Global Impression-Improvement Scale; CBCL Int, Anx = Child 
Behavior Checklist Internalizing and Anxiety Problem Scale; MASC = Multidimensional 
Anxiety Scale for Children, Total scale; PSWQ-C = Penn State Worry Questionnaire for 
Children; CAMM = Child and Adolescent Mindfulness Measure; MCQ-C Tot, Pos, Neg, 
Super, Cog = Metacognitions Questionnaire for Children, Total, Positive Meta-worry, 
Negative Meta-worry, Superstitious, and Cognitive Monitoring scales. 
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Table 11. Means and Standard Deviations of Change Scores in Outcome Measures in 
Combined Sample for Study 2 (N = 12) 
 Immediate (n = 6) Waitlist (n = 6) d 
GAD CSR -1.17 (1.17) -.33 (.82) .83 
CGAS 5.00 (10.04) 1.33 (3.14) .49 
CGI-S -.67 (.82) .17 (.41) 1.30 
CGI-I 3.00 (.63) 3.67 (.52) 1.16 
CBCL Internalizing -9.60 (.10) -2.50 (5.82) 1.41 
CBCL Anxiety -8.60 (6.11) -.67 (3.01) 1.65 
MASC Total -7.00 (15.51) -5.33 (4.18) .15 
PSWQ-C -14.00 (7.84) -2.33 (10.46) 1.26 
CAMM -.83 (5.46) 6.33 (6.81) 1.16 
MCQ-C Tot -6.67 (6.02) -6.83 (4.40) .03 
MCQ-C Cog -4.67 (3.88) -2.00 (2.90) .78 
 
Notes. GAD CSR = clinical severity rating of GAD; CGAS = Children’s Global 
Assessment Scale; CGI-S = Clinical Global Impression-Severity Scale; CGI-I = Clinical 
Global Impression-Improvement Scale; CBCL Int, Anx = Child Behavior Checklist 
Internalizing and Anxiety Problem Scale; MASC = Multidimensional Anxiety Scale for 
Children, Total scale; PSWQ-C = Penn State Worry Questionnaire for Children; CAMM 
= Child and Adolescent Mindfulness Measure; MCQ-C Tot, Cog = Metacognitions 
Questionnaire for Children, Total and Cognitive Monitoring scales. 
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Table 12. Demographic Information, Diagnostic Status, and Clinical Severity at Pre-
Treatment, Post-Treatment, and 8-week Follow-Up for Study 2 (N = 12) 
Participant Demographic Info   Diagnostic Status (CSR; 0-8 scale) 
 Age Ethnicity Gender  Pre Post 8-wk F/U 
5 9 Caucasian Male  GAD (6) GAD (4) GAD (3) 
     OCD (2) OCD (0) OCD (0) 
6 9 Caucasian Female  GAD (5) GAD (4) GAD (5) 
     ODD (4) ODD (4) ODD (4) 
7 11 Caucasian Male  GAD (5) GAD (4) GAD (4) 
     Spec (2) Spec (0) Spec (0) 
8 12 Caucasian Male  GAD (5) GAD (3) GAD (4) 
9 12 African-
American 
Male  GAD (4) GAD (2) GAD (1) 
10 12 Caucasian Male  GAD (6) GAD (4) GAD (3) 
11 12 Caucasian Female  GAD (6) GAD (6) GAD (6) 
12 10 Caucasian Male  GAD (6) GAD (6) GAD (2) 
     SOC (4) SOC (0) SOC (0) 
     ODD (5) ODD (5) ODD 3) 
13 11 Caucasian Female  GAD (4) GAD (4) GAD (1) 
14 9 Caucasian Female  GAD (5) GAD (2) GAD (4) 
     SOC (4) SOC (4) SOC (5) 
15 10 Caucasian Female  GAD (5) GAD (3) GAD (3) 
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16 11 Biracial Male  GAD (5) GAD (3) GAD (3) 
 
Notes. Pre-treatment data includes pre-treatment for immediate treatment group and 
post-waitlist data for waitlist group; CSR = Clinical Severity Rating, a score of 4 or 
above is considered to be a clinical diagnosis; GAD = Generalized Anxiety Disorder; 
SOC = Social Phobia; Spec = Specific Phobia. 
  
79 
79 
Appendix A 
 
 
 
 
 
The AWARE Program: 
Approaching Worries Actively through Reflection and Experience 
 
A Mindfulness-based Treatment for Children with Generalized Anxiety Disorder 
 
 
Priscilla T. Chan, M.A. 
Lisa S. Coyne, Ph.D. 
Martha C. Tompson, Ph.D. 
 
 
v. 11/2013 
 
 
 
 
 
 
  
80 
80 
Overview of Treatment Rationale 
Note to Parents and Clinicians: 
Mindfulness is about practicing how to be focused and non-judgmental in the present 
moment in our day-to-day life. As Kabat-Zinn (1994) writes, “mindfulness means paying 
attention in a particular way: on purpose, in the present moment, and 
nonjudgmentally…this kind of attention nurtures greater awareness, clarity, and 
acceptance of present-moment reality” (p. 4). Therefore, mindfulness is defined as having 
a nonjudgmental awareness and attention to the present and can be achieved through the 
practice of mindfulness meditation as well as other practices. Through mindfulness, one 
can learn to be open and accepting of one’s thoughts, both positive and negative, on a 
moment-to-moment basis. In addition to accepting one’s thoughts, mindfulness 
encourages a focus on internal sensations and emotions and external stimuli.  
Mindfulness-based treatments have been shown in research to help adults across a range 
of problems and disorders including chronic pain (Kabat-Zinn, 1982; Reibel et al., 2001), 
anxiety (Kabat-Zinn et al., 1992), depression (Segal et al., 2002; Teasdale et al., 2000), 
post-traumatic stress disorder (Wolfsdorf & Zlotnick, 2001), and eating disorders 
(Kristeller & Hallett, 1999).  
This will be an adapted mindfulness treatment for children.  The treatment is aimed at 
helping children learn a different way of understanding their thoughts (both worried and 
coping thoughts) and feelings (both emotions and physical sensations). One of the goals 
is for children to learn how to be mindful and reflective of each and every situation rather 
than reacting reflexively. In this way, a secondary goal of teaching children mindfulness 
coping skills is to alleviate their everyday worries and anxieties. 
By practicing mindfulness through these session exercises, the hope is that children will 
cultivate an attitude of awareness in everyday situations.  
Please note that the order of sessions can be flexible. It may be helpful to give the child 
the choice of which type of mindfulness skill they want to learn and practice next. If kids 
have a difficult time being mindful to internal sensations, like breathing, it may be helpful 
to start with external mindfulness activities, such as mindful listening and mindful eating.  
Note: Italicized text is meant to be a guideline script for the clinician. 
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Introduction to Mindfulness  
Content 
Goal 
• Introduction to Mindfulness 
o What is Mindfulness 
o Judging versus noticing 
o Importance of practicing at home 
Materials • Worksheets 
 
Introduction (parent + child) 
Welcome the parent and child together and explain the structure of the next 6 weeks 
(meeting once a week for approximately 60 minutes each week). Child will be meeting 
with the therapist for the majority of the session learning and practicing different 
mindfulness exercises. At the end of every session, the parent will be invited back into 
the room and the child will teach his/her parent the mindfulness skill learned in session. 
Mindfulness homework will be assigned for practice throughout the week and the parent 
is strongly encouraged to practice these exercises with his/her child. These exercises will 
take between 10-20 minutes daily. 
 
Psychoeducation (parent + child) 
Nature of anxiety 
• All emotions, including anxiety, are natural, necessary, and harmless – 
experienced by everyone and part of the experience of being human. Can anxiety 
ever be good?  
• Anxiety can be helpful (protect yourself from danger) and unhelpful (no danger 
present, too intense or too frequent). So, sometimes anxiety can be good because 
it protects us from danger, but sometimes anxiety is not helpful because there is 
no real danger. 
• Since anxiety is a reaction, we can learn ways of managing anxiety. And because 
anxiety can be helpful, the goal of treatment is not to remove all anxiety but to 
help you become more aware so that you can decide what to do in the situation. 
We are going to learn how to observe your anxiety so that you can decide how to 
respond. 
 
What is Mindfulness? + Rationale for Treatment 
• Have you ever noticed times when you weren’t paying attention? For instance, 
not paying attention when you get home from school and then realizing that you 
didn’t know where you put your book bag or homework papers?  
 
[Elicit examples from parent and child] 
 
Everyone has moments like this when we aren’t very good about paying attention 
or being aware of what’s going on right now. What can happen is that when kids 
get anxious, we can get stuck with worrying about things that happened in the 
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past or getting stuck worrying about what might happen in the future. Has that 
happened to you? 
 
What can get lost is thinking about what’s happening right now. Throughout our 
6 weeks together, we’ll learn how to pay more attention by being aware of our 
thoughts whether they are positive or negative, noticing our feelings like being 
sad, happy, or worried and being aware of feelings in our bodies. By learning 
how to pay attention to what’s going on in the moment, you can enjoy life more 
and not get stuck worrying. When we learn how to do this, we can decide what to 
do about something in the moment instead of just acting and worrying. This is 
called “mindfulness” or “being mindful.” Being “mindful” means being aware of 
what we do, think, and feel in situations that make us worried or anxious. Another 
way to say it is that we can learn to respond more thoughtfully and reflectively 
rather than acting automatically. By practicing mindfulness, we can start to 
experience every day moments in a new way, perhaps noticing things we hadn’t 
noticed before and learning that our thoughts and feelings aren’t necessarily 
“good” or “bad” but part of our every day experiences. Mindfulness might 
change your relationship with worry – worries might boss you around and 
mindfulness can help you change that. Also, by being mindful, we become more 
aware when we do feel worried and learn to be okay with those feelings, whether 
we label them as “good” or “bad.” 
 
Most kids and adults learning how to do mindfulness and practicing it have some 
trouble at first doing it. It can take a while to get there. It’s tricky! And we’ll talk 
about ways to help you figure out how to do it. It’s definitely going to take some 
practice and allowing yourself room to make mistakes here and there.  
 
Judging versus Noticing 
• One part of mindfulness is noticing rather than judging. Judging is when you 
decide something is bad or good. Noticing is about saying the facts. Have you 
ever tasted something you didn’t like and thought, “That’s gross”?  
 
[Let child respond] 
 
Instead of judging that food as “gross” how could you have thought about it 
differently and notice your reactions?  
 
[Let child respond] 
 
Maybe you could think to yourself, “Hm, that tastes different.” Or, have you been 
nervous and messed up? Being mindful might mean thinking “Okay, I messed up 
and right now I’m feeling ____” and describe what you feel without judging 
yourself, instead of thinking, “Gosh, I’m so stupid.”  If this sounds hard, it can 
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be!  Throughout these next 6 weeks, we’ll learn how to get better at noticing 
instead of judging, having present moment awareness without defense.  
 
Practicing Mindfulness at home 
• We’ll be learning lots of different exercises and some of will seem to really relate 
to what you do when you are worried and some of the skills we learn might not 
seem to relate as much. It’s important to keep in mind that all of the exercises will 
help you learn WAYS to be mindful in your everyday life so even if it doesn’t seem 
to help your worries right away, I think the more we practice being mindful in 
your normal life, the more it will be helpful to you. Also, it will be really 
important that you make sure to practice these exercises at home with your 
mom/dad. It will usually only take about 10-20 minutes a day to practice. Just like 
any skill, like playing an instrument/computer or video game really well or 
knowing how to shoot a basketball, we will need to practice every day to get 
better at being mindful. Hopefully these practices will be fun and if you have 
trouble remembering or doing them at home, let me know and we’ll work together 
to figure out the best way for you to practice outside of session.  
• Give Mindful Tips HANDOUT to parent(s) 
 
Beginning Session Check-In: How are you feeling? (child) 
Ask the child to describe how they are feeling at the beginning of the session.  
• [Ask child] Why do you think we are going to rate how you feel each time we 
meet? 
o Happy 
o Sad 
o Mad 
o Worried 
o Any other emotions? 
 
Getting to Know You Game (child)  
Play a get to know you game and find out 5 interesting facts about the child. Use this 
game as an exercise to practice mindfulness by paying attention to what the other person 
is saying and then trying to remember at the end of session what he/she has shared with 
you. 
Questions that you can ask: 
• Favorite color 
• Favorite vacation spot 
• Favorite (spring/summer/fall/winter) activity 
• Favorite sports/music/tv shows/movie/etc. 
 
Before introducing new Mindfulness Skill 
• What do you do now when you feel worried/anxious? 
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AFTER FIRST SESSION: Problem Solving Barriers to Everyday Mindful Practice 
(parent + child) 
If parent and/or child had any difficulties in maintaining a regular practice over the week, 
work together with them to figure out a plan for the coming week. 
• Finding a regular consistent time to practice together (right after school, after 
dinner, before bedtime, etc.) and scheduling it into the day 
• Maybe involving other family members so that it can be a family activity 
• What other difficulties were encountered? 
• If you find that your mind wanders or you are making judgments about the 
exercise (“This is boring,” “This is weird,” etc.), that’s OKAY! This is part of 
practicing mindfulness.  
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Mindful Eating  
Content 
Goal 
• Problem solving barriers to practice 
• Mindful Eating 
Materials • Raisins 
• Orange slices 
• M&M’s 
• Gummy worms 
• Crackers 
 
Checking In (parent + child) 
Review last session and mindfulness skill learned (if applicable) – elicit responses from 
parent and child, too. 
Review practice assignment and ask both parent and child how their mindful practice 
went over the past week: 
• What did they notice? 
• Were they judging or noticing? 
• Any difficulties about maintaining every day practice? 
 
Beginning Session Check-In: How are you feeling? (child) 
Ask the child to describe how they are feeling at the beginning of the session.  
• Happy 
• Sad 
• Mad 
• Worried 
• Any other emotions? 
  
Introduction to Mindful Eating 
Eating is an everyday activity that we can often do without really being in the 
moment. How many times have you been eating, and without realizing it, all of a 
sudden, you feel full or maybe not notice how much you were eating? Has that 
ever happened to you or can you think of any times when maybe you weren’t 
being mindful while eating? We can practice mindfulness in just about all of our 
everyday activities and today we’ll be starting with eating. 
 
Raisin Exercise (Based on Kabat-Zinn. From Segal, Z. V., Williams, J. M. G., & 
Teasdale, J. D. (2002). Mindfulness-Based Cognitive Therapy for Depression. NY: 
Guilford.) 
Begin by assuming a mindful posture – how are you sitting on the chair/on the 
floor, you might notice the feeling of air on your skin, you might notice your 
breaths.  
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Then begin to focus on the object in front of you and just imagine that you have 
never seen anything like it before. Imagine you have just come from another 
planet at this moment and you have never seen anything like it before in your life. 
Taking one of these objects and holding it in the palm of your hand, or between 
your finger and thumb. Paying attention to seeing it. Looking at it carefully, as if 
you had never seen such a thing before. Turning it over between your fingers.  
How does the object look? What colors describe the object? Notice where the 
light shines on it. Use your eyes to explore every part of it, like you’ve never seen 
it before. If you notice any thoughts or feelings that come up as you are looking at 
this object, just note them as thoughts and return your attention to the object. 
How does the object feel in your hands – is it soft or hard? Is it bumpy or smooth? 
Now use your nose to smell the object, with each breath, notice its smell. Use all 
your senses to examine it. 
 
And now slowly putting the object into your mouth and use your tongue to explore 
it. You might notice its texture or its taste. Perhaps you might notice your mouth 
watering as it is in your mouth. You might notice you have thoughts and feelings 
about the object or you might notice that your mind has wandered. 
Now when you’re ready, gently bite into the object. You might notice that the 
texture has changed or that it tastes differently. Slowly chew the object, taking 
your time to notice the different sensations in your mouth. As you swallow it, 
notice if you have any sensations in your throat while it goes to your stomach. 
Again, notice what thoughts or feelings you have at this exact moment and 
realizing that now your body is exactly one raisin heavier. 
 
Repeat exercise but with different foods (orange slices, chocolate M&M’s, gummy 
worms, crackers, etc.) 
Questions to ask after Mindful Eating exercises: 
• How did you feel during the exercise? 
• What thoughts did you notice you had? 
• Were you noticing or any times you felt like you were judging? 
• Did you notice any body sensations while you were breathing mindfully? 
• Was there a moment when your mind wandered?  
 
After Exercise Check-In: How are you feeling? 
Check in with the child about how they are feeling at the end of the session? Compare to 
how he/she was feeling at the beginning of session. 
• Let’s take a moment to notice how you are feeling. Tell me… 
 
Teaching Mindful Eating to Parent (parent + child) 
Invite the parent back into the session and have the child walk the parent through taking 
mindful eating. As needed, teach the parent together or the child can read the script to the 
parent. Ask similar follow-up questions to the parent and encourage child to share his/her 
experiences when doing mindful eating. 
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Emphasize that bringing greater attention or awareness to everyday activities, such as 
eating, can enrich our day to day life, make normal, everyday things more enjoyable. 
 
Mindfulness Practice: (parent + child) 
• Mindful Eating – Take at least 5 minutes in which both parent and child are 
mindfully eating – this can be during a meal time or snack time. Share with one 
another what you noticed while doing mindful eating. Make sure to record any 
feelings, thoughts, or body sensations you noticed before and after mindful eating. 
• Before parent and child leave, plan out together with them when they will do this 
activity every day.  
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Mindful Touching  
Content 
Goal 
• Mindful Touching 
Materials • Variety of objects with different textures: hairbrush, bubble 
wrap, pumice stone, stress ball, etc. 
• Handkerchief to be used as a blindfold or bag/box 
• Brown paper bag (if needed) 
 
Checking In (parent + child) 
Review last session and mindfulness skill learned (if applicable) – elicit responses from 
parent and child, too. 
Review practice assignment and ask both parent and child how their mindful practice 
went over the past week: 
• What did they notice? 
• Were they judging or noticing? 
• Any difficulties about maintaining every day practice? 
 
Beginning Session Check-In: How are you feeling? (child) 
Ask the child to describe how they are feeling at the beginning of the session.  
• Happy 
• Sad 
• Mad 
• Worried 
• Any other emotions? 
 
Introduction to Mindful Touching 
Today we’ll learn about mindfulness through our sense of touch. As we have 
learned about mindfulness with breath awareness and mindful eating, when we 
are being present in the moment, being mindful while we are touching objects, we 
might notice that we have certain judgments about things that we never noticed 
before. Being mindful will help us to look at these objects in a new way, just like 
we looked at the raisin in a new way.  
 
Blindfold the child and one by one, place an object into the child’s hands and let the child 
explore the object with his/her hands. If the child is not comfortable with being 
blindfolded, the child can close his/her eyes instead and put his/her hands into a brown 
paper bag to feel the different objects. 
 
Hold the object in your hand and, using your hands, explore the object with your 
hands through your sense of touch. Try to describe the object without naming it 
and making judgments about the object. Instead notice how it feels in your hands 
in this moment. 
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If the child describes the object by its name, gently direct the child to describe it without 
naming it and without judgment, so statements like “it feels nice” or “this feels gross” are 
subjective and not objective. Instead help the child use descriptive words such as sticky, 
prickly, hard, smooth, soft, rough, etc. If the child continues to have difficulty, ask open-
ended questions about how object feels: 
• Does it feel soft or hard?  
• How heavy is it? 
• Is the object big or small? 
• Does it feel warm or cold? 
 
Questions to ask after Mindful Touching exercise: 
• What was it like to use only your sense of touch? 
• Did you notice any times you were judging the object instead of noticing? 
o We can often do this in our everyday life, or when just focusing on one 
sense, we can misjudge something.  
• How was cultivating mindfulness in touching different than everyday life? 
• Did using only your sense of touch change how you “saw” an object? 
 
How to apply Mindful Touching in Everyday Life 
You can choose to bring a mindful awareness in any moment in your life just as 
you did with this exercise! For example, one day you might be having feelings of 
sadness, or anger, or happiness. In that moment, you might choose to take a 
mindful stance and instead of putting judgments on those feelings (like “This 
stinks” or “I wish I wasn’t feeling this way right now”), you might instead simply 
notice you have those feelings without labeling them as good or bad, and not 
trying to change them. Just as you noticed how an object felt “gooey” instead of 
thinking “this feels gross.” In this way, you can cultivate a mindful awareness 
and just be in the present moment. 
Another way to bring mindful awareness into your day to day life is for you to 
imagine what your worry would look, feel, taste, smell, sound like if it were a 
physical object! Let’s take a moment to do this. If your worry was an object, how 
would you describe it?  
 
After Exercise Check-In: How are you feeling? 
Check in with the child about how they are feeling at the end of the session? Compare to 
how he/she was feeling at the beginning of session. 
• Let’s take a moment to notice how you are feeling. Tell me… 
 
Teaching Mindful Touching to Parent (parent + child) 
Invite the parent back into the session and have the child walk the parent through mindful 
touching. Have the child blindfold the parent for the exercise. As needed, teach the parent 
together. Make this as interactive and fun as you can – perhaps the parent and child can 
take turns mindfully touching objects and asking questions to one another about their 
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experience. Ask similar follow-up questions to the parent and encourage child to share 
his/her experiences when doing mindful touching. 
 
Mindfulness Practice: (parent + child) 
• Mindful Touching – Take at least 5 minutes in which both parent and child are 
mindfully touching different household objects. Share with one another what you 
noticed while doing mindful touching. Did you experience an everyday object in a 
different way? Did the act of describing an object change how you experienced 
it? Make sure to record any feelings, thoughts, or body sensations you noticed 
before and after mindful touching. 
• Before parent and child leave, plan out together with them when they will do this 
activity every day.  
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Mindful Movement  
Content 
Goal 
• Mindful Movement 
Materials • Yoga mat 
 
Checking In (parent + child) 
Review last session and mindfulness skill learned (if applicable) – elicit responses from 
parent and child, too. 
• What did they notice? 
• Were they judging or noticing? 
• Any difficulties about maintaining every day practice? 
 
Beginning Session Check-In: How are you feeling? (child) 
Ask the child to describe how they are feeling at the beginning of the session.  
• Happy 
• Sad 
• Mad 
• Worried 
• Any other emotions? 
 
Introduction to Mindful Movement (Walking) 
Another way to cultivate an attitude of mindfulness is by paying attention to how 
our body moves. Sometimes what we feel in our bodies is in indication of the 
emotions we are feeling. Have you ever noticed that if you are worried about 
something like speaking in front of our class, you might notice your heart 
pounding, or if you are excited about your birthday party, you might feel like 
jumping up and down in excitement? So it can be helpful and important to really 
notice and pay attention to how your body feel because that can help you figure 
out how you are feeling. And with mindfulness, we want to have an attitude of 
non-judgment, just noticing and not labeling feelings as good or bad. By being 
more aware of your body, you might feel that you can really be focused and 
attentive to the present moment more so than during other times during the day. 
 
Begin by noticing how your feet feel being “grounded.” You might notice that the 
ground is hard, or that your feet feel squishy in your shoes. Gently bring 
awareness to your feet as you begin to walk slowly around the room. How does 
your foot feel with each step – heavy, light? Pay attention to how your foot knows 
how to lift up and down as you walk slowly. Notice which part of your foot 
touches the ground first – is it your heel or your toe? Does your body adjust or 
shift when one foot lifts off the ground? Maybe stop and stand still and notice the 
difference between walking slowly and standing. As you begin walking again, do 
you notice any thoughts coming into your head about how this feels? If you notice 
that you might be judging, just make note of that gently and then shift your focus 
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back on describing to yourself. Now, being mindful of your body, start walking 
more quickly. How do the sensations in your body change?  
Continue the exercise by asking the child to increase speed and decrease speed. After 
giving guidance for the first 5 minutes or so, you can stop the verbal instruction and let 
the child have space to continue mindful movements at his/her own pace. [total time = 10 
minutes] 
 
Continuing Mindful Movement (Yoga + other movements) 
Practicing yoga poses is another experiential learning exercise that can assist the child in 
becoming more aware of their body and movements.  
! Tree Pose: 1. Stand up straight. Look at one spot in front of you to keep a steady 
posture and gaze. 2. Bend your right knee and place your right leg on your left 
leg, above the knee or below the knee, whichever is more comfortable. 3. Now 
stretch your arms up above you.   
! Butterfly Pose: 1. Sit on the floor and place the bottoms of your feet together. 
Hold on to your feet or ankles. 2. Gently let your knees drop toward the floor 
while sitting up with a tall spine.  
! Airplane Pose: 1. Stand up straight and tall. Stretch your arms out by the side of 
your body like an airplane. 2. Dip your body forward at your waist as you point 
one foot behind you. 3. Try to keep balanced as your chest is in front of you and 
one foot is behind you.  It might help to keep your eyes on one spot. 4. Now try 
Airplane pose with the other foot. 
 
Seaweed (adapted from Amy Saltzman): imagine your body is a piece of seaweed at the 
bottom of the ocean…how would you be moving? What if a big wave comes through – 
how would that change your movements? 
 
Questions to ask after Mindful Movement exercise: 
• What was it like to pay attention to how we move our bodies? 
• Did you notice any times you were judging instead of noticing? 
• Anything you learned about yourself? 
• Did using only your sense of movement change how you experienced walking or 
stretching? 
 
After Exercise Check-In: How are you feeling? 
Check in with the child about how they are feeling at the end of the session? Compare to 
how he/she was feeling at the beginning of session. 
• Let’s take a moment to notice how you are feeling. Tell me… 
 
Teaching Mindful Movement to Parent (parent + child) 
Invite the parent back into the session and have the child walk the parent through taking 
mindful movement (both walking and yoga pose = maybe 1 minute for each). As needed, 
teach the parent together or the child can read the script to the parent. Ask similar follow-
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up questions to the parent and encourage child to share his/her experiences when doing 
mindful movement. 
 
Mindfulness Practice: (parent + child) 
• Mindful Movement – Take at least 5 minutes in which both parent and child are 
either practicing mindful walking around the house or outside, or trying the yoga 
poses together. Share with one another what you noticed while doing mindful 
movement. Make sure to record any feelings, thoughts, or body sensations you 
noticed before and after mindful movement. 
• Before parent and child leave, plan out together with them when they will do this 
activity every day.  
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Mindful Listening  
Content 
Goal 
• Mindful Listening  
Materials • Different instrumental music clips 
 
Checking In (parent + child) 
Review last session and mindfulness skill learned (if applicable) – elicit responses from 
parent and child, too. 
• What did they notice? 
• Were they judging or noticing? 
• Any difficulties about maintaining every day practice? 
 
Beginning Session Check-In: How are you feeling? (child) 
Ask the child to describe how they are feeling at the beginning of the session.  
• Happy 
• Sad 
• Mad 
• Worried 
• Any other emotions? 
 
Introduction to Mindful Listening  
It’s easy to become used to all the noises and sounds we hear everyday. 
Sometimes we won’t notice until it seems suddenly quiet in a room what sounds 
were present. Has that happened to you before, maybe you really noticed the 
ticking of the clock or the small whirring of a fan? We don’t realize how many 
sounds are present because we forget to pay attention. Sounds can also bring 
about different feelings or emotions for us or even memories. Maybe hearing the 
sound of waves brings you back to a happy memory of a summer vacation or 
hearing a police siren causes you to become irritated because it’s loud. Being 
mindful of sounds won’t change the sound itself but it will probably change your 
experience of it – like mindful eating or touching, our relationship to sounds will 
be different. You might start to notice sounds that were always there before but 
you never realized. You might feel like you are experiencing sounds in a new, 
fresh way. 
 
Let’s begin by first taking 5 mindful breaths to come into a stance of mindfulness. 
Close your eyes and as you listen to the sounds, note anything thoughts, feelings, 
or body sensations to come up for you. Try to note the sounds as just sounds and 
not as “good” or “bad.” 
 
Play 1 minute sound clips of different instrumental songs – 3 to 4 clips in total. After 
each clip, ask the child to write down what thoughts, feelings, or body sensations arise as 
they listened paying attention to whether they “noticed” or “judged.”  
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Take the child outside, weather permitting, and take 2-3 minutes for the child to practice 
mindful listening outside.  
Questions to ask after Mindful Listening exercise: 
• What thoughts, feelings, or body sensations did you notice while listening? 
• How can these be related to the sounds you hear? 
• What made you have certain responses to each sound clip? 
 
Share your own thoughts, feelings, body sensations that you had while listening to the 
same sound clips. Discuss with child how a person’s own previous experiences might 
shape how they perceive a sound. You might note to the child that your experience of the 
sounds was different than his/her own experience. But also note there is not “right” or 
“wrong” way. 
 
After Exercise Check-In: How are you feeling? 
Check in with the child about how they are feeling at the end of the session? Compare to 
how he/she was feeling at the beginning of session. 
• Let’s take a moment to notice how you are feeling. Tell me… 
 
Teaching Mindful Listening to Parent (parent + child) 
Invite the parent back into the session and have the child walk the parent through mindful 
listening. As needed, teach the parent together or the child can read the script to the 
parent. Ask similar follow-up questions to the parent and encourage child to share his/her 
experiences when doing mindful listening. 
 
Mindfulness Practice: (parent + child) 
• Mindful Listening – Take at least 5 minutes in which both parent and child are 
mindfully listening. This can be by listening to the radio, a sounds clip, sitting 
outside or just sitting in a room and listening to the noises present. Share with one 
another what you noticed while doing mindful listening. Make sure to record any 
feelings, thoughts, or body sensations you noticed before and after mindful 
listening. 
• Before parent and child leave, plan out together with them when they will do this 
activity every day. Suggest that this could be a fun exercise to do while parent and 
child run errands.  
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Mindful Breathing  
Content 
Goal 
• Introduction to Mindfulness 
o What is Mindfulness 
o Judging versus noticing 
o Importance of practicing at home 
Materials • Worksheets 
 
Checking In (parent + child) 
Review last session and mindfulness skill learned (if applicable) – elicit responses from 
parent and child, too. 
 
Review homework assignment and ask both parent and child how their breath awareness 
exercises went over the past week: 
• What did they notice? 
• Were they judging or noticing? 
• Any difficulties about maintaining every day practice? 
 
Mindfulness Exercise: Breath Awareness 
[Model each and every exercise with child and practice WITH the child] 
• Let’s start our first mindfulness exercise by taking “mindful breaths.” Remember, 
being mindful means paying attention, just notice any thoughts, feelings, or body 
sensations you have while we do this exercise. Practice paying attention to EACH 
breath. Let’s start out by being mindful of how you are sitting; you may want to 
sit up straighter if you like. You can close your eyes to help you pay more 
attention or you can also focus on a spot in the room. Take one deep breath in 
with your nose and hold it for 1 second and then breathe out slowly. Notice how 
the breath feels in your nose – your breath might feel warm or cold. You might 
notice how your breath travels down to your lungs. Take another deep breath in 
and another deep breath out. If you notice that your mind wanders, that’s okay. 
Notice that it has happened and bring your awareness back to your breaths. 
Breathe in again. Pause for 1 second and then breathe out. You might notice that 
your body, your shoulders move while you breathe in and out. Notice any 
thoughts you might be thinking – you may be thinking, “I’m breathing in and 
out.” Take your time and have full awareness and attention on your breaths. 
 
Questions to ask after Breath Awareness: 
• How did you feel during the exercise? 
• What thoughts did you notice you had? 
• Were you noticing or any times you felt like you were judging? 
• What body sensations did you notice while you were breathing mindfully? 
• Was there a moment when your mind wandered?  
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Bubble Exercise (adapted from Hooker & Fodor) to be introduced as child becomes 
more comfortable with mindfulness, such as later sessions: 
• As you are sitting with your eyes closed, imagine bubbles floating up in front of 
you. Each bubble contains a worry, a thought, a picture, or an image. See the first 
bubble float up. What do you see inside the bubble? What do you notice about the 
bubble? See the thought or worry, and watch the bubble continue to rise up and 
gently float away. Try not to judge it and once it floats away, notice the next 
bubble to floats up in front of you. What do you see in that bubble? 
 
After Exercise Check-In: How are you feeling? 
Check in with the child about how they are feeling at the end of the session? Compare to 
how he/she was feeling at the beginning of session. 
• Let’s take a moment to notice how you are feeling. Tell me… 
 
Teaching Mindful Breathing to Parent (parent + child) 
Invite the parent back into the session and have the child walk the parent through taking 
mindful breaths. As needed, teach the parent together or the child can read the script to 
the parent. Ask similar follow-up questions to the parent and encourage child to share 
his/her experiences when doing breath awareness. 
 
Mindfulness Practice: (parent + child) 
• Breath Awareness – Take at least 5 mindful breaths with parent. Share with one 
another what you noticed while doing mindful breathing. Make sure to record 
how you were feeling before and after mindful breathing. 
• Encourage parent that practice these mindfulness exercises WITH the child rather 
than enforcing it. 
• Before parent and child leave, plan out together with them when they will do this 
activity every day 
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Termination and Everyday Mindfulness 
Content 
Goal 
• Review of mindfulness skills learned 
• Examining child’s overall experience with mindfulness 
• Using mindfulness in everyday life 
• Taking stock of all you accomplished 
Materials • Mindfulness worksheets 
• Graduation certificate 
 
Checking In (parent + child) 
Review Practice assignment and ask both parent and child how their mindful listening 
exercises went over the past week: 
• What did they notice? 
• Were they judging or noticing? 
• Any difficulties about maintaining every day practice? 
 
Reviewing Mindfulness + Being Mindful in Everyday Life 
Today is our last session together. Let’s spend some time talking about what 
you’ve learned about mindfulness and yourself over the past 6 weeks. First, let’s 
take 5 mindful breaths together. 
 
How would you describe mindfulness to a friend?  
 
What do you remember from the first time you came here? 
 
What have you learned about yourself over the past several weeks? 
 
How has your experience or relationship with your worries changed over time? 
 
Do you see any differences in how you respond now in different situations? 
 
What will you remember from this experience? 
 
Do you have any goals you want to set for yourself for the future? 
 
Any specific things you want to continue practicing? 
 
Although this is the end of our time together, how can you continue to practice 
what you have learned about mindfulness going forward?  
(Some ideas may be to continue practicing taking mindful breaths when 
feeling a certain emotion; taking time each week to do something 
mindfully like eating, touching, smelling) 
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Graduation Certificate Presentation (parent + child) 
Invite the parent back into the session and have the child discuss with parent what he/she 
has learned about mindfulness and how he/she might commit to practicing mindfulness in 
everyday life. Present a graduation certification for the child.
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Mindfulness Treatment for Generalized Anxiety 
 
What is Mindfulness? 
Mindfulness is about practicing how to be focused and non-judgmental in the present 
moment in our day-to-day life. Through practicing mindfulness exercises, one can learn 
to be open and accepting of one’s thoughts, both positive and negative, on a moment-to-
moment basis. In addition to accepting one’s thoughts, mindfulness encourages a focus 
on internal sensations and emotions and external stimuli.  
When kids are anxious, they get stuck with worrying about things that happened in the 
past or getting stuck worrying about what might happen in the future. What can get lost is 
thinking about what’s happening right now. This mindfulness treatment is aimed at 
helping your child learn a different way of understanding his/her thoughts (both worried 
and coping thoughts) and feelings (both emotions and physical sensations). One of the 
goals is for your child to learn how to be mindful and reflective of each and every 
situation rather than reacting automatically. Thus, using mindfulness skills can help your 
child cope and manage his/her everyday worries and anxieties. By learning how to pay 
attention to what’s going on in the moment, your child may be able to enjoy life more and 
not get stuck worrying. He/she can then decide what to do about something in the 
moment instead of just acting and worrying.  
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Mindfulness Exercise Tips for Parents 
 
• Plan out exactly when you and your child will practice mindfulness 
each day.  
 
• Try to find a place to practice without too many distractions (ex: 
television, other kids, toys, etc.) 
 
• Use a timer to keep track of time, especially for exercises that are 5 
minutes. 
 
• Actively practice each exercise WITH your child. 
 
• It’s OKAY if you and your child notice your mind wandering or find 
practicing mindfulness hard. It happens! ☺ Just notice it and gently 
remind yourself to bring your attention and focus back on the specific 
exercise. 
 
• Allow yourself and your child room to make mistakes here and there.  
 
• Don’t forget to praise your child for his/her efforts. 
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Mindfulness Practice 
1. Practice 5 minutes of mindful breaths. Practice imagining your worried thoughts as 
clouds floating by. 
2. Take 5 minutes to eat mindfully by using your fingers, eyes, nose, ears, and mouth. 
3. Take 5 minutes to listen mindfully and notice what feelings and emotions you have 
while listening. Notice if you are making any judgments instead of noticing. 
4. Take 5 minutes to touch mindfully whether that’s when you’re eating, doing 
homework, etc. 
5. OR take 5 minutes to move mindfully when you’re walking to school, doing an errand 
with mom or dad. 
6. Remember, it’s OKAY if your mind wanders. Just notice it, and gently try to bring 
your attention back to your mindful exercise. 
 
****Practice at least once each day**** 
Circle: """ ☺ if you have practiced mindful breathing"
    if you have practiced mindful eating!
" "if you have practiced mindful touching!
!if you have practiced mindful listening!
" " "if you have practiced mindful movement!
x"""if you have not practiced  
"
"
" What did you notice BEFORE the practice? 
(thoughts, feelings, and body 
sensations) 
What did you notice AFTER the 
practice? 
(thoughts, feelings, body sensations) 
Day 1 
☺/"x"
/"x"
"/"x"
!/"x"
" "
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"/"x"
Day 2 
☺/"x"
/"x"
"/"x"
!/"x"
"/"x!
"
"
"
"
"
"
"
"
"
"
"
"
Day 3 
☺/"x"
/"x"
"/"x"
!/"x"
"/"x!
" "
Day 4 
☺/"x"
/"x"
"/"x"
!/"x"
"/"x"
"/"x"
"
"
"
Day 5 
☺/"x"
" "
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/"x"
"/"x"
!/"x"
"/"x"
Day 6 
☺/"x"
/"x"
"/"x"
!/"x"
"/"x"
"
"
"
"
"
"
"
"
"
"
"
"
Day 7 
☺/"x"
/"x"
"/"x"
!/"x"
"/x"
" "
"
"
 !
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Appendix B 
Child and Adolescent Mindfulness Measure (CAMM) 
From Greco, Smith, & Baer, 2011: Table 1 
We want to know more about what you think, how you feel, and what you do. Read each 
sentence. Then, circle the number that tells how often each sentence is true for you. 
   
 Never True 
Rarely 
True 
Some-
times 
True 
Often 
True 
Always 
True 
1. I get upset with myself for having 
feelings that don’t make sense. 0 1 2 3 4 
2. At school, I walk from class to class 
without noticing what I’m doing. 0 1 2 3 
 
4 
 
3. I keep myself busy so I don’t notice my 
thoughts or feelings. 0 1 2 3 4 
4. I tell myself that I shouldn’t feel the 
way I’m feeling. 0 1 2 3 4 
5. I push away thoughts that I don’t like. 0 1 2 3 
 
4 
 
6. It’s hard for me to pay attention to only 
one thing at a time. 0 1 2 3 
 
4 
 
7. I get upset with myself for having 
certain thoughts. 0 1 2 3 4 
8. I think about things that have happened 
in the past instead of thinking about things 
that are happening right now. 
 
0 1 2 3 4 
9. I think that some of my feelings are bad 
and that I shouldn’t have them. 0 1 2 3 4 
10. I stop myself from having feelings that 
I don’t like. 0 1 2 3 4 
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Scoring Instructions: Compute total score on the CAMM by reverse scoring and 
summing all items. 
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Penn State Worry Questionnaire for Children (PSWQ-C) 
Directions. This form is about worrying. Worrying happens when you are scared about 
something and you think about it a lot. People sometimes worry about school, their 
family, their health, thing coming up future or other kinds of things. For each sentence 
that you read, circle the answer that best tells how true that sentence is about you. 
 
1. My worries really bother me. Never true 
Sometimes 
true 
Most times 
true 
Always 
true 
2. I don’t really worry about things. Never true 
Sometimes 
true 
Most times 
true 
Always 
true 
3. Many things make me worry.  Never true 
Sometimes 
true 
Most times 
true 
Always 
true 
4. I know I shouldn‘t worry about things, 
but I just can’t help it. 
Never 
true 
Sometimes 
true 
Most times 
true 
Always 
true 
5. When I’m under pressure, I worry a lot. Never true 
Sometimes 
true 
Most times 
true 
Always 
true 
6. I am always worrying about something. Never true 
Sometimes 
true 
Most times 
true 
Always 
true 
7. I find it easy to stop worrying when I 
want. 
Never 
true 
Sometimes 
true 
Most times 
true 
Always 
true 
8. When I finish one thing, I start to worry 
about everything else. 
Never 
true 
Sometimes 
true 
Most times 
true 
Always 
true 
9. I never worry about anything.  Never true 
Sometimes 
true 
Most times 
true 
Always 
true 
10. I’ve been a worrier all my life. Never true 
Sometimes 
true 
Most times 
true 
Always 
true 
11. I notice that I have been worrying 
about things. 
Never 
true 
Sometimes 
true 
Most times 
true 
Always 
true 
12. Once I start worrying, I can’t stop.  Never true 
Sometimes 
true 
Most times 
true 
Always 
true 
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13. I worry all the time. Never true 
Sometimes 
true 
Most times 
true 
Always 
true 
14. I worry about things until they are all 
done. 
Never 
true 
Sometimes 
true 
Most times 
true 
Always 
true 
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Meta-cognitions Questionnaire for Children (MCQ-C) 
From Cartwright-Hatton & Landon 2005, Revised 
 
We are interested in how young people think. Listed below are a number of beliefs that 
people have. Please read each item and say how much you generally agree with it by 
circling a number. Please respond to all the items.  There are no right or wrong answers. 
 
Sex:……………….  Age:…………… 
 
  Do 
not 
agree 
Agree 
slightly 
Agree 
moder-
ately 
Agree 
very 
much 
1. If I worry about things now, I will have 
fewer problems in the future 
 
 
1 
 
2 
 
3 
 
4 
2. It is not a good idea to worry because 
worrying is bad for me 
 
1 2 3 4 
3. I often notice the thoughts that I have in 
my head 
 
1 2 3 4 
4. If I worry a lot, I could make myself 
sick 
 
1 2 3 4 
5. When I am thinking about a problem in 
my head, I take note of how my mind 
works 
 
 
1 
 
2 
 
3 
 
4 
6. If I did not get a worry thought out of 
my head and then something bad 
happened, it would be my fault 
 
1 2 3 4 
7. Worrying about things helps me to be 
organized and keep my stuff in order 
 
1 2 3 4 
8. My worrying thoughts keep going, no 
matter how hard I try to put them out of 
my head 
 
1 2 3 4 
9. When I am confused, worrying helps 
me sort things out 
 
 
1 
 
2 
 
3 
 
4 
10. I can’t stop thinking of the things that I 1 2 3 4 
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worry about 
 
11.  I try hard to keep track of the thoughts 
that I have in my head 
1 2 3 4 
12. I should be able to tell myself to stop 
and start 
thinking about things whenever I want 
to 
1 2 3 4 
13. Worrying might make me go crazy 
 
1 2 3 4 
14. I am always thinking about the thoughts 
in my head 
1 2 3 4 
15. I pay a lot of attention to the way that I 
think 
1 2 3 4 
16. Worrying helps me feel better 
 
1 2 3 4 
17. If I can’t stop my thoughts, I am no 
good 
 
1 2 3 4 
 
18. Once I start worrying about something, 
I cannot stop 
 
1 2 3 4 
19. If I can’t stop my thoughts, bad things 
will happen 
 
1 2 3 4 
20. Worrying helps me solve problems 
 
1 2 3 4 
21. It is bad to think about certain things 
 
1 2 3 4 
22. If I couldn’t be in control of what I 
think, I would fall apart 
 
1 2 3 4 
23. I need to worry in order to get my work 
done 
 
1 2 3 4 
 
24. I think about my thoughts over and over 1 2 3 
 
4 
 
Please ensure that you have responded to all items  - Thank You. 
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Participant #: _________  Date: _______________     Post-Treatment 
 
Mindfulness Treatment - Parent Evaluation Form 
We would like to get some of your opinions about the treatment your child received in 
the Mindfulness Treatment Program.  Please answer each of the following questions as 
honestly as possible.  Circle the number which best reflects your feelings.  Circle the term 
“Not Applicable” if the question does not apply to you.   Remember, there are no right or 
wrong answers. 
 
 Not at all     Somewhat    Very Much  
1. How much did this treatment make 
sense to you in terms of decreasing your 
child’s anxiety?  
1 2 3 4 5 N/A 
2. How much do you think the treatment 
helped your child cope with anxiety?  
1 2 3 4 5 N/A 
3. How much do you think the treatment 
helped your child decrease his/her anxiety? 
1 2 3 4 5 N/A 
4. How confident would you be in 
recommending this treatment to a friend’s 
child who was having difficulties with 
anxiety?  
1 2 3 4 5 N/A 
5. How helpful do you think the in-session 
exercises were for treating your child’s 
anxiety? 
1 2 3 4 5 N/A 
6. How helpful do you believe the out-of-
session practices were for treating your 
child’s anxiety?  
1 2 3 4 5 N/A 
7. Overall, how much do you think your 
child’s anxiety improved by the end of the 
treatment?  
1 2 3 4 5 N/A 
8. How much do you think your child will 
use the skills and strategies that he/she 
learned in treatment in the future? 
1 2 3 4 5 N/A 
9. How much do you agree with this 
statement: “My child’s therapist was 
supportive.” 
1 2 3 4 5 N/A 
10. How do you agree with this statement: 
“My child’s therapist presented 
information to me clearly.”   
1 2 3 4 5 N/A 
11. How satisfied were you with the 
amount you were involved with your 
child’s treatment?   
1 2 3 4 5 N/A 
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 Less                                       More 
12. If you weren’t satisfied with your level 
of involvement, do you wish you had more 
or less involvement with your child’s 
treatment?  
1 2 3 4 5 N/A 
 
Please use the space below to answer the following questions. We appreciate your honest 
opinions. There are no right or wrong answers. If you need more space, you may use the 
back of this sheet. 
1. What did you find most helpful about the treatment you and your child received at 
the Center? Please explain. 
 
2. What part of treatment was least helpful? Please explain. 
 
3. What was the most important thing you learned throughout the course of your 
child’s treatment? 
 
4. How would you describe this treatment to a friend whose child also has anxiety? 
What advice would you give him/her based on what you learned at the Center? 
 
5. What would you change about the mindfulness treatment at the Center? 
 
 
6. Would you have preferred to be more or less involved with your child’s 
treatment? Please explain. 
 
7. If discontinuing your participation in the treatment, please give reasons for 
discontinuation. If not applicable, just leave this space blank. 
 
8. Please use the space below to make any comments or suggestions that you might 
have about the mindfulness treatment. 
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Participant #: _________  Date: _______________     Post-Treatment 
 
Mindfulness Treatment - Child Evaluation Form 
We would like to get some of your opinions about the treatment you received in the 
Mindfulness Treatment Program.  Please answer each of the following questions as 
honestly as possible. Circle the number which best reflects your feelings. Circle the term 
“Not Applicable” if the question does not apply to you. Remember, there are no right or 
wrong answers. 
 
 Not at all     Somewhat    Very Much  
1. How much did this treatment make 
sense to you in terms of decreasing your 
anxiety?  
1 2 3 4 5 N/A 
2. How much do you think the treatment 
helped you cope with anxiety? 
1 2 3 4 5 N/A 
3. How much do you think the treatment 
helped you decrease your anxiety?  
1 2 3 4 5 N/A 
4. How confident would you be in 
recommending this treatment to a friend 
who was having difficulties with anxiety? 
1 2 3 4 5 N/A 
5. How helpful do you think the in-session 
exercises were for helping your anxiety? 
1 2 3 4 5 N/A 
6. How helpful do you think the out-of-
session practices were for helping your 
anxiety?  
1 2 3 4 5 N/A 
7. Overall, how much do you think your 
anxiety got better by the end of the 
treatment?  
1 2 3 4 5 N/A 
8. How much do you think you will use the 
skills and strategies that you learned in 
treatment in the future? 
1 2 3 4 5 N/A 
9. How much do you agree with this 
statement: “My therapist was supportive.” 
1 2 3 4 5 N/A 
10. How do you agree with this statement: 
“My therapist taught me the skills clearly.”  
1 2 3 4 5 N/A 
11. How satisfied were you with the 
amount your parent was involved with 
treatment?   
1 2 3 4 5 N/A 
 Less                                       More 
12. If you weren’t satisfied with your 
parent’s level of involvement, do you wish 
your parent had more or less involvement 
with your treatment?               
1 2 3 4 5 N/A 
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Please use the space below to answer the following questions. We appreciate your honest 
opinions. There are no right or wrong answers. If you need more space, you may use the 
back of this sheet. 
 
1. What did you find most helpful about the treatment you received at the Center? 
Please explain. 
 
 
2. What part of treatment was least helpful? Please explain. 
 
 
3. What was the most important thing you learned throughout the treatment? 
 
 
4. How would you describe this treatment to a friend whose child also has anxiety? 
What advice would you give him/her based on what you learned at the Center? 
 
 
5. What would you change about the mindfulness treatment at the Center? 
 
 
6. Did you find it helpful to have you parent(s) involved in treatment? Would you 
have liked them to be more or less involved? Please explain. 
 
 
7. What was the best session for you? Please explain. 
 
 
8. What was the worst session for you? Please explain. 
 
 
9. If discontinuing your participation in the project, please give reasons for 
discontinuation. 
 
 
10. Please use the space below to make any comments or suggestions that you might 
have about the mindfulness treatment. 
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Education 
 
2013 – Present  Pre-Doctoral Internship at the Boston Consortium in Clinical 
Psychology 
   Boston, MA 
Training Director: R. Keith Shaw, Ph.D., Stephen Quinn, Ph.D. 
Clinical Child Psychology Rotation: The SPARK Center  
Clinical Adult Psychology Rotation: Center for Returning Veterans – VA 
Boston Healthcare System Jamaica Plain Campus  
Appointments: Clinical Fellow in Psychiatry, Harvard Medical School; 
Teaching Fellow in Psychiatry, Boston University School of 
Medicine 
 
2008 – Present  Boston University       
   Boston, MA 
Doctoral Candidate in Clinical Psychology, anticipated 2014 
   The Family and Development Treatment Laboratory   
Advisor: Martha C. Tompson, Ph.D. 
The Center for Anxiety and Related Disorders (CARD) 
Advisor: Donna B. Pincus, Ph.D. 
Dissertation: Children with Generalized Anxiety Disorder: Developing a 
Mindfulness Intervention  
 
2008 – 2009  Boston University 
   Boston, MA 
   Master of Arts in Clinical Psychology 
Master’s Thesis: Stress Generation in a Family Context: The Role of 
Youth Depressive Symptoms and Family Stress 
  
2002 – 2006  Bowdoin College       
  Brunswick, ME 
Bachelor of Arts in Psychology, English (minor) 
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Honors and Awards 
 
2011   Clara Mayo Research Fellowship, $8,070.00 
   Boston University 
2008 American Psychopathological Association (APPA) Conference 
Travel Award 
   Boston University       
2005    Kibbe Science Fellowship 
   Bowdoin College      
2004    Freeman Fellowship for Study in Asia 
   Bowdoin College 
 
Clinical Experience 
 
Sept 2013 – present The Boston Consortium in Clinical Psychology      Boston, MA  
   Pre-Doctoral Psychology Intern 
   Training Director: R. Keith Shaw, Ph.D., Stephen Quinn, Ph.D. 
                  
Clinical Child Psychology Rotation: 
Boston Medical Center, Department of Pediatrics –The SPARK Center 
(Supporting Parents and Resilient Kids)  
Executive Director: Martha Vibbert, Ph.D. 
Supervisors: Cynthia Chase, Ph.D., Martha Vibbert, Ph.D. 
 
Conducting individual therapy and developmental and psychological 
assessments for children ages 0-5 affected with complicated medical 
conditions (including neuro-developmental challenges, failure to thrive, 
and HIV/AIDS) as well as families involved with the MA Department of 
Children and Families. Attending weekly didactics/trainings. Receiving 
weekly individual and group clinical supervision. 
 
Clinical Adult Psychology Rotation:  
Center for Returning Veterans – VA Boston Healthcare Systems Jamaica 
Plain Campus.  
Director: Erin S. Daly, Ph.D. 
Supervisor: Jill P. Scott, Ph.D. 
 
Conducting assessments and individual therapy for male and female 
returning veterans from Operation Enduring Freedom (OEF), Operation 
Iraqi Freedom (OIF), and Operation New Dawn (OND), who are 
experiencing a range of adjustment and mental health difficulties 
(including adjustment disorders, PTSD, depression, anxiety disorders, 
substance abuse). Conducting weekly intake assessments. Attending 
weekly differential diagnosis and treatment planning meetings. 
Receiving comprehensive and ongoing didactics in the use of evidence-
based treatments as well as weekly individual and group clinical 
supervision. 
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May 2012 – July 2013  Systems of Support (SOS) Study 
Boston University                       Boston, MA 
Protocol Therapist  
Principal Investigator/Supervisor: Martha C. Tompson, Ph.D. 
 
An NIMH funded 2-site randomized controlled trial to evaluate the 
efficacy of a family focused treatment as compared to individual 
psychotherapy for childhood depressive disorders. Trained in the use of 
Family-Focused Treatment (FFT) and Client-Centered Therapy. 
Conducting FFT with children with depression and their families. 
 
Aug 2008 – July 2013  Child and Adolescent Fear and Anxiety Program and Early 
Childhood Interventions Program at the Center for Anxiety and 
Related Disorders 
Boston University            Boston, MA 
Practicum – Clinician 
Co-Directors: Donna B. Pincus, Ph.D., Jonathan S. Comer, Ph.D. 
Supervisors: Donna B. Pincus, Ph.D., Jonathan S. Comer, Ph.D., 
Ovsanna Leyfer, Ph.D., Ryan Madigan, Psy.D., Matthew Hersh, Ph.D., 
Jennifer Trachtenberg, Ph.D., Sarah W. Whitton, Ph.D. 
 
Provided individual and group cognitive-behavioral therapy for children 
and adolescents with various anxiety disorder diagnoses, including 
Separation Anxiety Disorder, Generalized Anxiety Disorder, Social 
Phobia, Trichotillomania, Specific Phobia, Obsessive-Compulsive 
Disorder, and Selective Mutism. Conducted semistructured clinical 
assessments using the Anxiety Disorders Interview Schedule for the 
DSM-IV, Child/Parent Version (ADIS-IV-C/P). Attended weekly 
differential diagnosis and treatment planning meetings. Received 
comprehensive and ongoing didactics in the use of evidence-based 
treatments for anxiety disorders as well as weekly clinical supervision. 
  
Sept 2011 – May 2012  Psychology Assessment Center 
Massachusetts General Hospital          Boston, MA 
Practicum – Clinical Assessor 
Supervisors: Kay Seligsohn, Ph.D., Margaret Pulsifer, Ph.D. 
 
Developed test administration and scoring skills, including cognitive, 
academic, neuropsychological and some projective tests. Developed 
behavioral observation and interpretation skills. Exposure to a variety of 
medical and behavioral/emotional diagnoses. Attended weekly didactic 
seminars. Received one hour of weekly supervision. In addition, 
observed neuropsychological evaluations conducted by MGH staff and 
post-doctoral fellows. 
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Aug 2011, 2012  Summer Treatment Program for Selective Mutism (BU Brave 
Buddies) 
Boston University            Boston, MA 
Clinician 
Director/Supervisor: Jami Furr, Ph.D. 
 
Administered behavioral treatment in a one-week intensive group format 
to children ages 3-7 diagnosed with Selective Mutism. The BU Brave 
Buddies Camp simulated a classroom environment, which provided 
guided opportunities for these children to interact with a number of new 
children and adults, participate in classroom-like activities, engage in 
field trips, and play socializing games that promote verbal participation 
and spontaneous speaking. Responsibilities included co-leading group 
sessions, assisting with camp activities, and joining the campers on 
exposure tasks. 
 
Aug 2010 – June 2010  The Manville School at Judge Baker Children’s Center   Boston, MA 
Practicum – Clinical Extern 
Supervisor: James Slavet, Ph.D. 
 
Served as a clinical case manager and primary clinical mental health 
treatment provider for children ages 7-16 in a therapeutic day school. 
Conducted weekly psychotherapy for children diagnosed with 
Depression, Anxiety, Bipolar, and Autistic Spectrum Disorders. Led 
weekly meetings with classroom teachers, educational specialists, 
behavioral health counselors, parents, and external health providers for 
therapy cases. Co-led a 9-week-long CBT parent management training 
group for parents of Manville students and co-led a 6-week-long CBT 
group for siblings of Manville students focusing on coping with a family 
member with mental health difficulties. Administered psychological and 
educational testing to assist in treatment planning and the development of 
Individualized Education Plans (IEP). Provided applied behavioral 
consultation to classroom staff to assist in developing and achieving 
individual student behavioral and educational goals. 
 
Sept 2009 – July 2010  Psychological Services Center 
Boston University                        Boston, MA 
Practicum – Clinician 
Director: Lisa Smith, Ph.D. 
Supervisor: Aisha Usmani, Ph.D. 
 
Conducted individual cognitive-behavioral therapy for adults with 
various mood and anxiety disorders. Received weekly live observation as 
well as individual and group clinical supervision. Responsibilities 
included conducting intake assessments using the Anxiety Disorders 
Interview Schedule (ADIS), case conceptualization, treatment planning, 
and intervention administration. 
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Sept 2009 – July 2010  Neuropsychological Testing at the Psychological Services Center 
Boston University            Boston, MA 
Practicum – Clinician 
Director: Lisa Smith, Ph.D. 
Supervisor: Rosemary Toomey, Ph.D. 
 
Administered and interpreted various tests of intelligence, achievement, 
memory, attention, and executive functioning. Received comprehensive 
didactic instruction and observation experience in test administration, 
scoring procedures, testing theory, and interpretation. Responsibilities 
included assessment conceptualization, test administration, and writing 
integrative summary reports. 
 
June 2009, 2010  Summer Treatment Program for Separation Anxiety Disorder 
Boston University            Boston, MA 
Protocol Clinician 
Supervisor: Lauren C. Santucci, M.A. 
 
Administered cognitive-behavioral treatment (CBT) in a one-week 
intensive summer camp format to girls ages 7 to 12 diagnosed with 
Separation Anxiety Disorder. Responsibilities included co-leading CBT 
group sessions, assisting with camp activities, and joining the campers on 
exposure tasks (e.g. field trips that required separation from 
parents/guardians). 
 
Research Experience 
 
Sept 2011 – Dec 2013  Doctoral Dissertation  
   Boston University           Boston, MA 
   Principal Investigator 
Readers: Martha C. Tompson, Ph.D., Donna B. Pincus, Ph.D., Boston 
University; Lisa S. Coyne, Ph.D., Suffolk University 
 
Proposed and received acceptance for dissertation entitled: “Children 
with Generalized Anxiety Disorder: Developing a Mindfulness 
Intervention.” Received IRB approval. Conducting ongoing subject 
recruitment, providing a 6-week mindfulness treatment for children ages 
9-12 with primary Generalized Anxiety Disorder, and conducting data 
collection and analysis. 
 
Sept 2012 – July 2013  A Controlled Trial of Telemethods to Expand the Availability of 
Parent-Child Interaction Therapy for Disruptive Preschoolers 
Boston University           Boston, MA 
   Independent Evaluator 
   Principal Investigator/Supervisor: Jonathan S. Comer, Ph.D. 
 
A study funded by the Charles H. Hood Foundation Child Health 
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Research Award evaluating internet-delivered Parent-Child Interaction 
Therapy (PCIT) versus a waitlist control for the treatment of disruptive 
behavior disorders in young children. Conducted pre- and post-treatment 
internet-delivered diagnostic assessments with study participants using 
the Kiddie-Disruptive Behavior Disorders Schedule for Preschool 
Children (KDBD) and Dyadic Parent-Child Interaction Coding System 
(DPICS). 
 
Aug 2011 – July 2013 Evaluating the feasibility of Internet-delivered Parent-Child 
Interaction Therapy 
Boston University           Boston, MA 
   Independent Evaluator 
   Principal Investigator/Supervisor: Jonathan S. Comer, Ph.D. 
 
An NIMH-funded study evaluating internet-delivered versus in-clinic-
delivered Parent-Child Interaction Therapy (PCIT) for the treatment of 
disruptive behavior disorders in young children. Conducted pre- and 
post-treatment diagnostic assessments with study participants using the 
Kiddie-Disruptive Behavior Disorders Schedule for Preschool Children 
(KDBD) and Dyadic Parent-Child Interaction Coding System (DPICS). 
 
Aug 2011 – July 2013 Internet-delivered Exposure and Response Prevention for early-
onset Obsessive-Compulsive Disorder: A pilot feasibility trial 
Boston University           Boston, MA 
   Independent Evaluator 
   Principal Investigator/Supervisor: Jonathan S. Comer, Ph.D. 
 
A pilot feasibility study funded by the International Obsessive 
Compulsive Disorder Foundation (IOCDF) evaluating internet-delivered 
family-based Exposure and Response Prevention (EX/RP) for the 
treatment of obsessive-compulsive disorder in young children. 
Conducted pre- and post-treatment diagnostic assessments with study 
participants using the Anxiety Disorders Interview Schedule for the 
DSM-IV, Child/Parent Version (ADIS-IV-C/P). 
 
Aug 2009 – July 2013 Systems of Support (SOS) Study                        
   Boston University               Boston, MA 
   Project Diagnostician 
   Principal Investigator/Supervisor: Martha C. Tompson, Ph.D. 
 
An NIMH funded 2-site randomized controlled trial to evaluate the 
efficacy of a family focused treatment as compared to individual 
psychotherapy for childhood depressive disorders. Responsibilities 
included conducting diagnostic assessments of children aged 7-15 and 
their parents; providing feedback reports to parents; drafting and editing 
consent and assent forms for IRB approval; brainstorming and 
implementing recruitment strategies; rating treatment adherence. Trained 
in the use of Family-Focused Treatment and Client-Centered Therapy. 
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Aug 2008 – July 2009 Families’ and Children’s Adjustment Study 
Boston University             Boston, MA 
Project Diagnostician       
Principal Investigator: Martha C. Tompson, Ph.D. 
Supervisors: Martha C. Tompson, Ph.D., Claudette B. Pierre, Ph.D. 
 
An NIMH funded research study exploring the links between risk and 
vulnerability in the development of child psychopathology, specifically 
the impact of expressed emotion, life events and maternal depression. 
Responsibilities included conducting in-home diagnostic assessments of 
children aged 8-12 and their mothers; writing feedback letters to 
participants summarizing assessments conducted and general 
impressions of individual and family functioning; and co-rating 
assessments for reliability. 
 
June 2006 – June 2008 Family Development and Treatment Lab 
Boston University             Boston, MA
 Research Assistant  
Director: Martha C. Tompson, Ph.D. 
Supervisor: Claudette B. Pierre, Ph.D.  
 
Responsibilities included administration of multiple clinical and 
psychosocial assessments to children aged 8-12 and their mothers; 
writing feedback letters to participants; assisting with grant writing and 
submission; conducting literature reviews; participant recruitment and 
scheduling; creating coding manuals for study measures; and supervising 
undergraduate research assistants in coding and scoring of lab data. 
 
Jan – April 2005 The Anna Freud Centre         London, UK 
Research Assistant Extern      
 Advisor: Saul Hillman, MSc.  
      
Transcribed and coded data for the Story Stems Standardisation Project, 
a study assessing children’s expectations and perceptions of family roles, 
attachments and relationships. Assisted a graduate student in conducting 
interviews for The Chinese Soho Project, a qualitative study on the 
impact of immigration on Chinese families living in the UK and the 
effect of immigration on the parent-child relationship.  
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Sept 2005 – May 2006 Developmental Psychology Lab 
Bowdoin College      Brunswick, ME  
 Research Assistant      
 Advisor: Samuel P. Putnam, Ph.D.  
       
Coded 100 videotapes on child behavior during a delay-of-gratification 
task. Performed library research and assisted in drafting an introduction 
for a research article.  
 
May – Aug 2005 Neuropsychology Lab 
Bowdoin College      Brunswick, ME 
Research Assistant       
 Advisor: Richmond R. Thompson, Ph.D. 
 
Awarded Kibbe Science Fellowship and conducted 5 studies, including 
pilot tests, researching peripheral manipulations on social approach 
behavior in male goldfish using Isoproterenol, Atropine, and Substance 
P. Significantly found that Substance P increases ventilation rate in 
goldfish.  
 
Jan – May 2004  Bowdoin’s Children’s Center 
Bowdoin College     Brunswick, ME 
Undergraduate Intern       
 Advisor: Suzanne B. Lovett, Ph.D.  
       
Worked with preschool children in conjunction with Bowdoin’s Infant 
and Child Development course. Supervised and observed different 
preschooler activities. Correlated observations with course work and 
implemented studies that were learned in class.  
 
Supervision and Teaching Experience 
 
Sept 2011 – July 2013 Child Program at the Center for Anxiety and Related Disorders 
Boston University           Boston, MA 
  Volunteer Coordinator 
  Supervisor: Jami Furr, Ph.D. 
 
  Provided oversight to a group of undergraduate student research 
assistantsfor the Child Program at the Center for Anxiety and Related 
Disorder. Provided didactic seminars through which volunteers learned 
professional development issues and current research in the field of 
childhood anxiety.  
 
Oct 2011, 2012  Clinical Seminar Series at the Psychological Services Center 
   Boston University            Boston, MA 
   Guest Lecturer 
   Supervisor: Lisa Smith, Ph.D. 
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Taught a 2-hour seminar course on relaxation and mindfulness treatment 
skills to 2nd year clinical psychology doctoral students. 
 
Sept 2011 – July 2012  Psychological Services Center 
Boston University           Boston, MA 
Graduate Student Supervisor 
Supervisor: Lisa Smith, Ph.D. 
 
Clinical supervisor to a junior graduate student clinician in the provision 
of empirically supported treatments to a caseload of two adult and two 
child patients with range of diagnoses. Provided live and taped 
observation of therapy and training in case conceptualization and 
treatment planning. Received weekly didactics and supervision with a 
licensed clinical supervisor. 
 
Jan – May 2012  Undergraduate Abnormal Psychology Course 
   Boston University           Boston, MA 
   Teaching Fellow 
               Advisor: Donna B. Pincus, Ph.D. 
 
Taught four weekly one-hour discussion sections of Abnormal 
Psychology. Met individually with students to provide extra help with 
course material. Other responsibilities included: creating and grading 
examinations and grading papers.  
 
Sept – Dec 2011 Undergraduate Introductory Psychology Course 
   Boston University           Boston, MA 
   Teaching Fellow 
               Advisor: Barak Caine, Ph.D. 
 
Taught four weekly one-hour discussion sections of Introductory 
Psychology. Met individually with students to provide extra help with 
course material. Other responsibilities included: creating and grading 
examinations, and grading papers.  
 
Jan – May 2010, 2011 Family Development and Treatment Laboratory 
   Boston University           Boston, MA 
   Undergraduate Directed Study Supervisor 
   Supervisor: Martha C. Tompson, Ph.D. 
 
Mentored two undergraduate psychology students in the creation of a 
directed study research paper and conference poster submission. 
Responsibilities included: teaching literature review skills, overseeing 
creation of topic, and editing and critiquing paper outlines and drafts. 
 
Sept 2008 – Aug 2009  Family Development and Treatment Laboratory 
Boston University           Boston, MA  
   Life Stress Interview Training Coordinator 
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Supervisors: Martha C. Tompson, Ph.D., Claudette B. Pierre, Ph.D.  
 
Trained doctoral-level graduate students and undergraduates in rating the 
ULCA Life Stress Interview, coordinated life stress events coding group 
of six coders, developed ongoing reliability assessments of coding, and 
trained research assistants in coding of project measures and supervised 
progress. 
 
Sept – Dec 2005 Introductory Psychology Course 
Bowdoin College      Brunswick, ME 
Teaching Assistant       
 Advisor: Richmond R. Thompson, Ph.D.  
     
Facilitated weekly study group sessions and met with students to provide 
extra help with the course material.  
 
Publications 
 
Chan, P. T., Doan, S. N., & Tompson, M. C. (in press). Stress generation in a developmental 
context: The role of youth depressive symptoms, maternal depression, the parent-child 
relationship, and family stress. Journal of Family Psychology. 
 
Freed, R. D., Chan, P. T., Langer, D. A., Tompson, M. C. (in press). Depression, bipolar disorder 
and suicidality in children and adolescents. In S. G. Hoffman, D. Dozois, J. A. Smits, & W. Rief 
(Eds.) Cognitive Behavioral Therapy: A Complete Reference Guide. Wiley Publishing. 
 
Comer, J.S., Furr, J.M., Cooper-Vince, C., Kerns, C., Chan, P.T., Edson, A.L., Khanna, M., 
Franklin, M.E., Garcia, A.M., & Freeman, J.B. (in press). Internet-delivered treatment for early-
onset OCD: A preliminary case series. Journal of Clinical Child and Adolescent Psychology. 
 
Comer, J.S., Furr, J.M., Cooper-Vince, C., Madigan, R. J., Chow, C., Chan, P.T., Idrobo, F., Chase, 
R., McNeil, C. B. & Eyberg, S. M. (in press). Rationale and considerations for the Internet-based 
delivery of Parent-Child Interaction Therapy. Cognitive and Behavioral Practice. 
Comer, J.S., Chow, C., Chan, P. T., Cooper-Vince, C., & Wilson, L.A.S. (2013). Psychosocial 
treatment efficacy for disruptive behavior problems in very young children: A meta-analytic 
examination. Journal of the American Academy of Child and Adolescent Psychiatry, 52, 26-36. 
 
Freed, R. D., Chan, P. T., Boger, K. D., & Tompson, M. C. (2012). Enhancing maternal 
depression recognition in health care settings: A review of strategies to improve detection, reduce 
barriers, and reach mothers in need. Family Systems & Health, 30, 1-18. 
 
Gallo, K. P., Chan, P. T., Buzzella, B. A., Whitton, S. W., & Pincus, D. B. (2012). The impact of 
an eight-day intensive treatment for adolescent Panic Disorder and Agoraphobia on comorbid 
diagnoses. Behavior Therapy, 43, 153-159. doi:10.1016/j.beth.2011.05.002  
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Tompson, M. C., Pierre, C. B., Dingman Boger, K., McKowen, J. W., Chan, P. T., & Freed, R. 
D. (2010).  Maternal depression, maternal expressed emotion and child psychopathology. Journal 
of Abnormal Child Psychology, 38, 105-117.   
 
Manuscripts Under Review/In Preparation 
 
Chan, P. T., & Tompson, M. T. (in preparation). Treating pediatric Generalized Anxiety 
Disorder using mindfulness: A case series.  
 
Comer, J.S., Elkins, R.M., Edson, A., Kerns, C.E., & Chan, P.T. (in preparation). 
Transdiagnostic versus diagnosis-specific protocols in the treatment of pediatric mood and 
anxiety disorders: A meta-analysis. 
Symposia 
 
Chan, P.T., and Elkins, R. M. (Co-Chairs), Comer, J. S. (Discussant), Rudy, B. M., Elkins, R. 
M., Graire, M. G. (2013, Nov). Breaking down brief treatments: Mediators, moderators, and 
predictors of outcome in intensive treatments for childhood anxiety disorders. Symposium 
presented at the 47th annual convention of the Association for Behavioral and Cognitive 
Therapies (ABCT), Nashville, TN. 
 
Kern, C., Chan, P.T., Cooper-Vince, C.E., Edson, A.L., Elkins, R.M., Furr, J.M., Madigan, R., & 
Comer, J.S. (2013, Sept) Internet-based Parent-Child Interaction Therapy delivered to the home: 
Video illustrations I. Paper presented at the 2013 Biennial PCIT International Convention. 
Boston, MA. 
 
Chan, P.T., Cooper-Vince, C.E., Edson, A.L., Elkins, R.M., Furr, J.M., Kerns, C., Madigan, R., 
& Comer, J.S. (2013, Sept) Internet-based Parent-Child Interaction Therapy delivered to the 
home: Video illustrations II. Paper presented at the 2013 Biennial PCIT International Convention. 
Boston, MA. 
 
Edson, A.L., Cooper-Vince, C.E., Chan, P.T., Elkins, R.M., Furr, J.M., Kerns, C., Madigan, R., 
& Comer, J.S. (2013, Sept) Internet-based Parent-Child Interaction Therapy delivered to the 
home: An overview of current clinical trials. Paper presented at the 2013 Biennial PCIT 
International Convention. Boston, MA. 
 
Elkins, R.M., Cooper-Vince, C.E., Chan, P.T., Edson, A.L., Furr, J.M., Kerns, C., Madigan, R., 
& Comer, J.S. (2013, Sept) Internet-based Parent-Child Interaction Therapy delivered to the 
home: Preliminary findings. Paper presented at the 2013 Biennial PCIT International Convention. 
Boston, MA. 
 
Comer, J.S. (Moderator), Cooper-Vince, C.E., Chan, P.T., Edson, A.L., Elkins, R.M., Furr, J.M., 
Kerns, C., & Madigan, R. (2013, Sept) Internet-based Parent-Child Interaction Therapy delivered 
to the home: Clinical considerations. Paper presented at the 2013 Biennial PCIT International 
Convention. Boston, MA. 
 
Chan, P. T., and Kerns. C. (Co-Chairs), Coyne, L. W. (Discussant), Woidneck, M. R., Twohig, 
M. P., Miller, A., & Liehr, P. (2012, Nov.). Developmentally Informed Applications of 
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Mindfulness, ACT, and DBT for Childhood Internalizing Disorders. Symposium presented at the 
46th annual convention of the Association for Behavioral and Cognitive Therapies (ABCT), 
National Harbor, MD. 
 
Chan, P. T., and Sacks, H. A. (Co-Chairs), Kurtz, S. (Discussant), Beidel, D., Furr, J. M., 
Mendlowitz, S., & Shipon-Blum, E. (2012, Nov). Breaking the Sound Barrier: Exploring 
Effective Behavioral Treatments for Childhood Selective Mutism. Symposium presented at the 
46th annual convention of the Association for Behavioral and Cognitive Therapies (ABCT), 
National Harbor, MD. 
 
Chan, P. T. and Pincus, D.B. (Co-Chairs), Roemer, L. (Discussant), Coyne, L.W., Remmes, C., 
& Freedman, M. L. (2011, Nov). Reducing Child and Youth Anxiety through Mindfulness and 
Acceptance-based  
Treatment Components: Linking Research to Practice. Symposium presented at the 45th annual 
convention of the Association for Behavioral and Cognitive Therapies (ABCT), Toronto, Canada. 
 
Tompson, M. C., Pierre, C. B., Freed, R. D., McKowen, J. W., Chan, P. T., Cruise, R. C., 
Smetana, C. S. (2010, Nov). Maternal Expressed Emotion and Internalizing Symptoms in Youth. 
In J. R. Asarnow (Discussant) & M. C. Tompson (Chair), Family Processes and Depression in 
Youth: Predictors and Mechanisms. Symposium presented at the 44th annual convention of the 
Association for Behavioral and Cognitive Therapies (ABCT), San Francisco, CA. 
 
Poster Presentations 
 
Rousseau, C. H., Chan, P. T., Freed, R. D., Langer, D. A., & Tompson, M. C. (2012, Nov). 
Family interpersonal stress, negative attributional style, and depressive symptoms in youth: A 
longitudinal analysis. Poster presented at the 46th annual convention of the Association for 
Behavioral and Cognitive Therapies (ABCT), National Harbor, MD. 
 
Chan, P. T., Leyfer, O., & Pincus, D. B. (2010, Nov). Family and clinical characteristics of 
children and youth diagnosed with Generalized Anxiety Disorder. Poster presented at the Child 
and Adolescent Anxiety Special Interest Group poster session at the 44th annual convention of the 
Association for Behavioral and Cognitive Therapies (ABCT). San Francisco, CA.  
 
Gallo, K. P., Chan, P. T., Chow, C., Pincus, D. B., & Whitton, S. W. (2010, June). The impact of 
an eight-day intensive treatment for Adolescent Panic Disorder and Agoraphobia on specific 
comorbid diagnoses. Poster presented at the 6th World Congress of Behavioral and Cognitive 
Therapies (WCBCT). Boston, MA. 
 
Smetana, C. R., Chan, P. T.,  & Tompson, M. C. (2010, June). Coping with maternal depression: 
Relations between children’s coping strategies and child depression. Poster presented at the 6th 
World Congress of Behavioral and Cognitive Therapies (WCBCT). Boston, MA. 
 
Chan, P. T., Pierre, C. B., & Tompson, M. C. (2009, Nov). Stress generation in a family context: 
The role of youth depressive symptoms and family stress. Poster presented at the 43rd annual 
convention of the Association for Behavioral and Cognitive Therapies (ABCT). New York, NY. 
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Gallo, K. P., Chan, P. T., Pincus, D. B., & Whitton, S. W. (2009, Nov). The impact of an eight-
day intensive treatment for Adolescent Panic Disorder and Agoraphobia on comorbid diagnoses. 
Poster presented at the 43rd annual convention of the Association for Behavioral and Cognitive 
Therapies (ABCT). New York, NY. 
 
McKowen, J. W., Dingman Boger, K., Chan, P. T., Freed, R., Pierre, C. B., & Tompson, M. C. 
(2009, June). Predictors of life stress sensitivity in children. Poster presented at the 14th 
conference of the International Society for Research in Child and Adolescent Psychopathology 
(ISRCAP). Seattle, WA. 
  
Tompson, M. C., Pierre, C. B., Cruise, R. C., McKowen, J. W., & Chan, P. T. (2009, June). 
Impact of maternal depression and expressed emotion in youth. Poster presented at the 14th 
conference of the International Society for Research in Child and Adolescent Psychopathology 
(ISRCAP). Seattle, WA. 
 
Pierre, C. B., Chan, P. T., McKowen, J. W., Dingman Boger, K., Freed, R., & Tompson M. C. 
(2008, Mar). Maternal depression and expressed emotion in the prediction of child attachment 
cognitions and youth depressive symptoms. Poster presented at the 98th conference of the 
American Psychopathological Association (APPA). New York, NY. 
 
McKowen, J. W., Dingman Boger, K., Freed, R., Chan, P. T., Pierre, C. B., & Tompson, M. C. 
(2008, Mar). Social support as a buffer to youth depression: Do perceptions of support moderate 
the relationship between life stress, negative cognitions, and depressive symptoms? Poster 
presented at the 98th conference of the American Psychopathological Association (APPA). New 
York, NY. 
 
Freed, R., Pierre, C. B., Chan, P. T., Dingman Boger, K., McKowen, J. W., & Tompson, M. C. 
(2008, Mar). Parental Locus of Control: Predictions from Maternal Depression, Maternal 
Expressed Emotion, and Child Symptoms. Poster presented at the 98th conference of the American 
Psychopathological Association (APPA). New York, NY. 
 
McKowen, J. W., Chan, P. T., Tompson, M. C., & Pierre, C. B. (2007, Nov). Maternal 
depression, maternal schemas, self-cognitions and perceptions of social support as predictors of 
depression in children: A Moderated-Mediational Model. Poster presented at the 41st annual 
convention of the Association for Behavioral and Cognitive Therapies (ABCT). Philadelphia, PA. 
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